> top > docs > PMC:2065877 > spans > 13052-16979 > annotations

PMC:2065877 / 13052-16979 JSONTXT

Annnotations TAB JSON ListView MergeView

2_test

Id Subject Object Predicate Lexical cue
17997602-1702555-98185726 151-153 1702555 denotes 32

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T5547 0-4 NN denotes LMP1
T5548 5-13 VB denotes Promotes
T5549 14-15 NN denotes B
T5550 16-20 NN denotes Cell
T5551 21-29 NN denotes Survival
T5552 30-33 CC denotes and
T5553 34-47 NN denotes Proliferation
T5554 48-50 IN denotes In
T5555 51-56 NNP denotes Vitro
T5556 57-64 JJ denotes Primary
T5557 65-66 NN denotes B
T5558 67-71 NN denotes cell
T5559 72-80 NN denotes cultures
T5560 81-84 MD denotes can
T5561 85-87 VB denotes be
T5562 88-98 VB denotes maintained
T5563 99-106 IN denotes through
T5564 107-111 NN denotes CD40
T5565 112-120 NN denotes ligation
T5566 121-124 CC denotes and
T5567 125-140 NN denotes supplementation
T5568 141-145 IN denotes with
T5569 146-149 NN denotes IL4
T5570 150-151 -LRB- denotes [
T5571 151-153 CD denotes 32
T5572 153-154 -RRB- denotes ]
T5573 156-158 TO denotes To
T5574 159-170 VB denotes investigate
T5575 171-178 IN denotes whether
T5576 179-183 NN denotes LMP1
T5577 184-191 VB denotes affects
T5578 192-199 JJ denotes primary
T5579 200-201 NN denotes B
T5580 202-206 NN denotes cell
T5581 207-215 NN denotes survival
T5582 216-219 CC denotes and
T5583 220-233 NN denotes proliferation
T5584 233-234 -COMMA- denotes ,
T5585 235-246 NN denotes splenocytes
T5586 247-251 VB denotes were
T5587 252-260 VB denotes cultured
T5588 261-263 IN denotes in
T5589 264-267 DT denotes the
T5590 268-276 NN denotes presence
T5591 277-279 CC denotes or
T5592 280-287 NN denotes absence
T5593 288-290 IN denotes of
T5594 291-294 NN denotes IL4
T5595 295-298 CC denotes and
T5596 299-307 VB denotes analyzed
T5597 308-310 IN denotes by
T5598 311-314 NN denotes MTS
T5599 315-317 IN denotes as
T5600 318-319 DT denotes a
T5601 320-329 JJ denotes metabolic
T5602 330-336 NN denotes marker
T5603 336-337 -COMMA- denotes ,
T5604 338-340 IN denotes by
T5605 341-349 NN denotes ethidium
T5606 350-359 NN denotes monoazide
T5607 360-361 -LRB- denotes (
T5608 361-364 NN denotes EMA
T5609 364-365 -RRB- denotes )
T5610 366-375 NN denotes exclusion
T5611 376-379 IN denotes for
T5612 380-389 NN denotes viability
T5613 389-390 -COMMA- denotes ,
T5614 391-394 CC denotes and
T5615 395-397 IN denotes by
T5616 398-422 NN denotes 5-bromo-2′-deoxy-uridine
T5617 423-424 -LRB- denotes (
T5618 424-428 NN denotes BrdU
T5619 428-429 -RRB- denotes )
T5620 430-443 NN denotes incorporation
T5621 444-447 IN denotes for
T5622 448-461 NN denotes proliferation
T5623 463-465 IN denotes In
T5624 466-469 DT denotes the
T5625 470-473 NN denotes MTS
T5626 474-479 NN denotes assay
T5627 479-480 -COMMA- denotes ,
T5628 481-483 IN denotes as
T5629 484-492 VB denotes expected
T5630 492-493 -COMMA- denotes ,
T5631 494-505 NN denotes splenocytes
T5632 506-510 IN denotes from
T5633 511-520 JJ denotes wild-type
T5634 521-525 NN denotes mice
T5635 526-529 VB denotes did
T5636 530-533 RB denotes not
T5637 534-541 VB denotes survive
T5638 542-546 RB denotes even
T5639 547-551 IN denotes with
T5640 552-555 DT denotes the
T5641 556-564 NN denotes addition
T5642 565-567 IN denotes of
T5643 568-571 NN denotes IL4
T5644 572-575 JJ denotes due
T5645 576-578 TO denotes to
T5646 579-580 DT denotes a
T5647 581-585 NN denotes lack
T5648 586-588 IN denotes of
T5649 589-593 NN denotes CD40
T5650 594-602 NN denotes ligation
T5651 603-604 -LRB- denotes (
T5652 604-610 NN denotes Figure
T5653 611-613 NN denotes 3A
T5654 613-614 -RRB- denotes )
T5655 616-618 IN denotes In
T5656 619-627 NN denotes contrast
T5657 627-628 -COMMA- denotes ,
T5658 629-633 NN denotes LMP1
T5659 634-645 NN denotes splenocytes
T5660 646-649 VB denotes had
T5661 650-659 VB denotes increased
T5662 660-670 NN denotes metabolism
T5663 671-675 RB denotes even
T5664 676-678 IN denotes in
T5665 679-682 DT denotes the
T5666 683-690 NN denotes absence
T5667 691-693 IN denotes of
T5668 694-697 NN denotes IL4
T5669 697-698 -COMMA- denotes ,
T5670 699-704 WDT denotes which
T5671 705-708 VB denotes was
T5672 709-716 RB denotes further
T5673 717-725 VB denotes enhanced
T5674 726-730 IN denotes upon
T5675 731-739 NN denotes addition
T5676 740-742 IN denotes of
T5677 743-746 NN denotes IL4
T5678 748-757 JJ denotes Wild-type
T5679 758-761 CC denotes and
T5680 762-766 NN denotes LMP1
T5681 767-777 JJ denotes transgenic
T5682 778-786 NN denotes lymphoma
T5683 787-792 NN denotes cells
T5684 793-796 VB denotes had
T5685 797-801 JJ denotes high
T5686 802-808 NN denotes levels
T5687 809-811 IN denotes of
T5688 812-815 NN denotes MTS
T5689 816-824 NN denotes activity
T5690 825-829 RB denotes even
T5691 830-832 IN denotes in
T5692 833-836 DT denotes the
T5693 837-844 NN denotes absence
T5694 845-847 IN denotes of
T5695 848-851 NN denotes IL4
T5696 852-853 -LRB- denotes (
T5697 853-859 NN denotes Figure
T5698 860-862 NN denotes 3A
T5699 862-863 -RRB- denotes )
T5700 865-868 DT denotes The
T5701 869-873 NN denotes LMP1
T5702 874-884 JJ denotes transgenic
T5703 885-893 NN denotes lymphoma
T5704 894-899 NN denotes cells
T5705 900-903 VB denotes had
T5706 904-917 RB denotes approximately
T5707 918-924 RB denotes 4-fold
T5708 925-931 JJ denotes higher
T5709 932-935 NN denotes MTS
T5710 936-944 NN denotes activity
T5711 945-949 IN denotes than
T5712 950-953 DT denotes the
T5713 954-960 JJ denotes normal
T5714 961-971 JJ denotes transgenic
T5715 972-983 NN denotes lymphocytes
T5716 984-987 CC denotes and
T5717 988-992 VB denotes were
T5718 993-995 IN denotes at
T5719 996-1001 JJ denotes least
T5720 1002-1008 RB denotes 2-fold
T5721 1009-1015 JJ denotes higher
T5722 1016-1020 IN denotes than
T5723 1021-1024 DT denotes the
T5724 1025-1032 NN denotes control
T5725 1033-1041 NN denotes lymphoma
T5726 1043-1045 IN denotes As
T5727 1046-1056 RB denotes previously
T5728 1057-1066 VB denotes published
T5729 1066-1067 -COMMA- denotes ,
T5730 1068-1076 NN denotes lymphoma
T5731 1077-1084 RB denotes usually
T5732 1085-1093 VB denotes develops
T5733 1094-1096 IN denotes in
T5734 1097-1101 NN denotes mice
T5735 1102-1106 IN denotes over
T5736 1107-1109 CD denotes 12
T5737 1110-1112 NN denotes mo
T5738 1113-1115 IN denotes of
T5739 1116-1119 NN denotes age
T5740 1120-1123 CC denotes and
T5741 1124-1127 DT denotes all
T5742 1128-1132 NN denotes mice
T5743 1133-1136 VB denotes are
T5744 1137-1147 VB denotes sacrificed
T5745 1148-1150 IN denotes by
T5746 1151-1156 CD denotes 18–20
T5747 1157-1159 NN denotes mo
T5748 1161-1164 DT denotes The
T5749 1165-1169 NN denotes ages
T5750 1170-1172 IN denotes of
T5751 1173-1176 DT denotes the
T5752 1177-1187 JJ denotes transgenic
T5753 1188-1192 NN denotes mice
T5754 1193-1197 IN denotes with
T5755 1198-1200 CC denotes or
T5756 1201-1208 IN denotes without
T5757 1209-1217 NN denotes lymphoma
T5758 1218-1224 VB denotes ranged
T5759 1225-1232 IN denotes between
T5760 1233-1234 CD denotes 6
T5761 1235-1238 CC denotes and
T5762 1239-1241 CD denotes 20
T5763 1242-1244 NN denotes mo
T5764 1245-1248 JJ denotes old
T5765 1250-1255 EX denotes There
T5766 1256-1259 VB denotes was
T5767 1260-1262 DT denotes no
T5768 1263-1274 NN denotes correlation
T5769 1275-1282 IN denotes between
T5770 1283-1286 NN denotes age
T5771 1287-1290 CC denotes and
T5772 1291-1294 NN denotes MTS
T5773 1295-1303 NN denotes activity
T5774 2220-2223 NN denotes EMA
T5775 2224-2233 NN denotes exclusion
T5776 2234-2236 IN denotes of
T5777 2237-2242 JJ denotes CD19+
T5778 2243-2248 VB denotes gated
T5779 2249-2250 NN denotes B
T5780 2251-2256 NN denotes cells
T5781 2257-2265 VB denotes prepared
T5782 2266-2270 IN denotes from
T5783 2271-2274 CD denotes two
T5784 2275-2284 JJ denotes wild-type
T5785 2285-2288 CC denotes and
T5786 2289-2292 CD denotes two
T5787 2293-2297 NN denotes LMP1
T5788 2298-2308 JJ denotes transgenic
T5789 2309-2313 NN denotes mice
T5790 2314-2323 VB denotes indicated
T5791 2324-2325 DT denotes a
T5792 2326-2332 JJ denotes 2-fold
T5793 2333-2341 NN denotes increase
T5794 2342-2344 IN denotes in
T5795 2345-2354 NN denotes viability
T5796 2355-2357 IN denotes in
T5797 2358-2361 DT denotes the
T5798 2362-2366 NN denotes LMP1
T5799 2367-2377 JJ denotes transgenic
T5800 2378-2389 NN denotes lymphocytes
T5801 2390-2398 VB denotes compared
T5802 2399-2401 TO denotes to
T5803 2402-2411 JJ denotes wild-type
T5804 2412-2423 NN denotes lymphocytes
T5805 2425-2428 CD denotes Two
T5806 2429-2437 NN denotes examples
T5807 2438-2440 IN denotes of
T5808 2441-2445 NN denotes LMP1
T5809 2446-2456 JJ denotes transgenic
T5810 2457-2465 NN denotes lymphoma
T5811 2466-2471 NN denotes cells
T5812 2472-2475 VB denotes had
T5813 2476-2483 RB denotes greatly
T5814 2484-2493 VB denotes increased
T5815 2494-2503 NN denotes viability
T5816 2504-2508 WDT denotes that
T5817 2509-2512 VB denotes was
T5818 2513-2516 RB denotes not
T5819 2517-2526 VB denotes increased
T5820 2527-2529 IN denotes by
T5821 2530-2533 NN denotes IL4
T5822 2534-2543 NN denotes treatment
T5823 2543-2544 -COMMA- denotes ,
T5824 2545-2555 VB denotes indicating
T5825 2556-2560 IN denotes that
T5826 2561-2564 DT denotes the
T5827 2565-2573 NN denotes lymphoma
T5828 2574-2579 NN denotes cells
T5829 2580-2583 VB denotes are
T5830 2584-2595 JJ denotes independent
T5831 2596-2598 IN denotes of
T5832 2599-2602 NN denotes IL4
T5833 2603-2617 NN denotes co-stimulation
T5834 2618-2619 -LRB- denotes (
T5835 2619-2625 NN denotes Figure
T5836 2626-2628 NN denotes 3B
T5837 2628-2629 -RRB- denotes )
T5838 2631-2642 NN denotes Enhancement
T5839 2643-2645 IN denotes in
T5840 2646-2649 NN denotes MTS
T5841 2650-2658 NN denotes activity
T5842 2659-2662 VB denotes was
T5843 2663-2671 VB denotes observed
T5844 2672-2674 IN denotes in
T5845 2675-2679 NN denotes LMP1
T5846 2680-2690 JJ denotes transgenic
T5847 2691-2699 NN denotes lymphoma
T5848 2700-2705 NN denotes cells
T5849 2706-2708 IN denotes by
T5850 2709-2712 DT denotes the
T5851 2713-2721 NN denotes addition
T5852 2722-2724 IN denotes of
T5853 2725-2728 NN denotes IL4
T5854 2728-2729 -COLON- denotes ;
T5855 2730-2737 RB denotes however
T5856 2737-2738 -COMMA- denotes ,
T5857 2739-2742 NN denotes EMA
T5858 2743-2752 NN denotes exclusion
T5859 2753-2756 VB denotes did
T5860 2757-2760 RB denotes not
T5861 2761-2767 VB denotes reveal
T5862 2768-2769 DT denotes a
T5863 2770-2777 JJ denotes similar
T5864 2778-2786 NN denotes increase
T5865 2788-2792 DT denotes This
T5866 2793-2798 MD denotes could
T5867 2799-2806 VB denotes reflect
T5868 2807-2808 DT denotes a
T5869 2809-2819 NN denotes difference
T5870 2820-2823 IN denotes for
T5871 2824-2827 NN denotes IL4
T5872 2828-2839 NN denotes requirement
T5873 2840-2842 IN denotes in
T5874 2843-2846 DT denotes the
T5875 2847-2856 JJ denotes metabolic
T5876 2857-2865 NN denotes activity
T5877 2866-2872 IN denotes versus
T5878 2873-2876 DT denotes the
T5879 2877-2886 NN denotes viability
T5880 2887-2889 IN denotes of
T5881 2890-2894 NN denotes LMP1
T5882 2895-2905 JJ denotes transgenic
T5883 2906-2914 NN denotes lymphoma
T5884 2915-2920 NN denotes cells
T5885 2922-2930 IN denotes Although
T5886 2931-2941 NN denotes expression
T5887 2942-2944 IN denotes of
T5888 2945-2949 NN denotes LMP1
T5889 2950-2955 MD denotes could
T5890 2956-2963 VB denotes enhance
T5891 2964-2972 NN denotes survival
T5892 2973-2975 IN denotes of
T5893 2976-2989 JJ denotes non-malignant
T5894 2990-2997 JJ denotes primary
T5895 2998-3009 NN denotes lymphocytes
T5896 3009-3010 -COMMA- denotes ,
T5897 3011-3015 NNP denotes BrdU
T5898 3016-3029 NN denotes incorporation
T5899 3030-3038 VB denotes revealed
T5900 3039-3043 IN denotes that
T5901 3044-3048 NN denotes LMP1
T5902 3049-3059 NN denotes expression
T5903 3060-3065 RB denotes alone
T5904 3066-3069 VB denotes was
T5905 3070-3073 RB denotes not
T5906 3074-3084 JJ denotes sufficient
T5907 3085-3087 TO denotes to
T5908 3088-3094 VB denotes induce
T5909 3095-3108 NN denotes proliferation
T5910 3109-3111 IN denotes in
T5911 3112-3119 NN denotes culture
T5912 3120-3121 -LRB- denotes (
T5913 3121-3132 JJ denotes unpublished
T5914 3133-3137 NN denotes data
T5915 3137-3138 -RRB- denotes )
T5916 3140-3144 RB denotes Only
T5917 3145-3153 NN denotes lymphoma
T5918 3154-3159 NN denotes cells
T5919 3160-3163 VB denotes had
T5920 3164-3174 JJ denotes detectable
T5921 3175-3181 NN denotes levels
T5922 3182-3184 IN denotes of
T5923 3185-3189 NN denotes BrdU
T5924 3190-3203 NN denotes incorporation
T5925 3204-3212 VB denotes detected
T5926 3213-3215 IN denotes by
T5927 3216-3220 NN denotes flow
T5928 3221-3230 NN denotes cytometry
T5929 3231-3232 -LRB- denotes (
T5930 3232-3238 NN denotes Figure
T5931 3239-3241 NN denotes 3C
T5932 3241-3242 -RRB- denotes )
T5933 3244-3257 RB denotes Interestingly
T5934 3257-3258 -COMMA- denotes ,
T5935 3259-3263 NN denotes LMP1
T5936 3264-3272 NN denotes lymphoma
T5937 3273-3278 NN denotes cells
T5938 3279-3282 VB denotes had
T5939 3283-3296 RB denotes significantly
T5940 3297-3303 JJ denotes higher
T5941 3304-3310 NN denotes levels
T5942 3311-3313 IN denotes of
T5943 3314-3327 NN denotes proliferation
T5944 3328-3330 IN denotes in
T5945 3331-3341 NN denotes comparison
T5946 3342-3344 TO denotes to
T5947 3345-3348 DT denotes the
T5948 3349-3360 JJ denotes spontaneous
T5949 3361-3369 NN denotes lymphoma
T5950 3370-3374 WDT denotes that
T5951 3375-3384 VB denotes developed
T5952 3385-3387 IN denotes in
T5953 3388-3390 DT denotes an
T5954 3391-3404 JJ denotes LMP1-negative
T5955 3405-3415 NN denotes littermate
T5956 3416-3417 -LRB- denotes (
T5957 3417-3419 CD denotes 25
T5958 3419-3420 NN denotes %
T5959 3421-3427 IN denotes versus
T5960 3428-3429 CD denotes 4
T5961 3429-3430 NN denotes %
T5962 3430-3431 -RRB- denotes )
T5963 3433-3437 DT denotes This
T5964 3438-3444 JJ denotes higher
T5965 3445-3450 NN denotes level
T5966 3451-3453 IN denotes of
T5967 3454-3467 NN denotes proliferation
T5968 3468-3471 VB denotes was
T5969 3472-3480 VB denotes observed
T5970 3481-3483 IN denotes in
T5971 3484-3493 NN denotes lymphomas
T5972 3494-3498 WDT denotes that
T5973 3499-3506 VB denotes express
T5974 3507-3511 CC denotes both
T5975 3512-3516 JJ denotes high
T5976 3517-3518 -LRB- denotes (
T5977 3518-3523 JJ denotes Table
T5978 3524-3525 CD denotes 1
T5979 3525-3526 -COMMA- denotes ,
T5980 3527-3534 NN denotes LMP1-L2
T5981 3535-3538 CC denotes and
T5982 3539-3546 NN denotes LMP1-L3
T5983 3546-3547 -RRB- denotes )
T5984 3548-3551 CC denotes and
T5985 3552-3555 JJ denotes low
T5986 3556-3557 -LRB- denotes (
T5987 3557-3562 JJ denotes Table
T5988 3563-3564 CD denotes 1
T5989 3564-3565 -COMMA- denotes ,
T5990 3566-3573 NN denotes LMP1-L5
T5991 3573-3574 -RRB- denotes )
T5992 3575-3581 NN denotes levels
T5993 3582-3584 IN denotes of
T5994 3585-3589 NN denotes LMP1
T5995 3589-3590 -COMMA- denotes ,
T5996 3591-3601 VB denotes suggesting
T5997 3602-3606 IN denotes that
T5998 3607-3611 RB denotes even
T5999 3612-3617 JJ denotes small
T6000 3618-3625 NN denotes amounts
T6001 3626-3628 IN denotes of
T6002 3629-3633 NN denotes LMP1
T6003 3634-3636 VB denotes is
T6004 3637-3647 JJ denotes sufficient
T6005 3648-3650 TO denotes to
T6006 3651-3657 VB denotes induce
T6007 3658-3666 JJ denotes dramatic
T6008 3667-3674 NN denotes effects
T6009 3675-3677 IN denotes in
T6010 3678-3691 NN denotes proliferation
T6011 3693-3696 DT denotes The
T6012 3697-3702 NN denotes level
T6013 3703-3705 IN denotes of
T6014 3706-3719 NN denotes proliferation
T6015 3720-3723 VB denotes was
T6016 3724-3727 RB denotes not
T6017 3728-3736 VB denotes enhanced
T6018 3737-3741 IN denotes upon
T6019 3742-3745 NN denotes IL4
T6020 3746-3754 NN denotes addition
T6021 3754-3755 -COMMA- denotes ,
T6022 3756-3766 VB denotes confirming
T6023 3767-3770 DT denotes the
T6024 3771-3774 NN denotes IL4
T6025 3775-3787 NN denotes independence
T6026 3788-3796 VB denotes observed
T6027 3797-3799 IN denotes in
T6028 3800-3803 DT denotes the
T6029 3804-3813 NN denotes viability
T6030 3814-3821 NN denotes studies
T6031 3822-3823 -LRB- denotes (
T6032 3823-3829 NN denotes Figure
T6033 3830-3832 NN denotes 3C
T6034 3832-3833 -COLON- denotes ;
T6035 3834-3840 NN denotes Table1
T6036 3840-3841 -RRB- denotes )
T22664 1315-1319 NN denotes LMP1
T22665 1320-1328 VB denotes Promotes
T22666 1329-1330 NN denotes B
T22667 1331-1335 NN denotes Cell
T22668 1336-1344 NN denotes Survival
T22669 1345-1348 CC denotes and
T22670 1349-1362 NN denotes Proliferation
T22671 1363-1365 IN denotes In
T22672 1366-1371 NNP denotes Vitro
T22673 1372-1373 -LRB- denotes (
T22674 1373-1374 NN denotes A
T22675 1374-1375 -RRB- denotes )
T22676 1376-1379 NN denotes MTS
T22677 1380-1385 NN denotes assay
T22678 1386-1388 IN denotes of
T22679 1389-1400 NN denotes splenocytes
T22680 1401-1405 IN denotes from
T22681 1406-1408 NN denotes WT
T22682 1409-1412 CC denotes and
T22683 1413-1417 NN denotes LMP1
T22684 1418-1428 JJ denotes transgenic
T22685 1429-1433 NN denotes mice
T22686 1435-1446 NN denotes Splenocytes
T22687 1447-1451 VB denotes were
T22688 1452-1460 VB denotes cultured
T22689 1461-1463 IN denotes in
T22690 1464-1467 DT denotes the
T22691 1468-1476 NN denotes presence
T22692 1477-1478 -LRB- denotes (
T22693 1478-1482 JJ denotes grey
T22694 1483-1487 NN denotes bars
T22695 1487-1488 -RRB- denotes )
T22696 1489-1491 CC denotes or
T22697 1492-1499 NN denotes absence
T22698 1500-1501 -LRB- denotes (
T22699 1501-1506 JJ denotes black
T22700 1507-1511 NN denotes bars
T22701 1511-1512 -RRB- denotes )
T22702 1513-1515 IN denotes of
T22703 1516-1519 NN denotes IL4
T22704 1520-1523 IN denotes for
T22705 1524-1525 CD denotes 3
T22706 1526-1527 NN denotes d
T22707 1529-1532 DT denotes The
T22708 1533-1540 NN denotes results
T22709 1541-1544 VB denotes are
T22710 1545-1548 DT denotes the
T22711 1549-1553 JJ denotes mean
T22712 1554-1555 JJ denotes ±
T22713 1556-1559 NN denotes SEM
T22714 1560-1562 IN denotes of
T22715 1563-1573 JJ denotes triplicate
T22716 1574-1581 NN denotes samples
T22717 1582-1590 VB denotes averaged
T22718 1591-1595 IN denotes from
T22719 1596-1604 JJ denotes multiple
T22720 1605-1609 NN denotes mice
T22721 1610-1615 WRB denotes where
T22722 1616-1619 PDT denotes “n”
T22723 1620-1623 DT denotes the
T22724 1624-1630 NN denotes number
T22725 1631-1633 IN denotes of
T22726 1634-1638 NN denotes mice
T22727 1639-1647 VB denotes analyzed
T22728 1648-1650 VB denotes is
T22729 1651-1653 RB denotes as
T22730 1654-1661 VB denotes follows
T22731 1661-1662 -COLON- denotes :
T22732 1663-1664 NN denotes n
T22733 1665-1666 SYM denotes =
T22734 1667-1668 CD denotes 2
T22735 1669-1672 IN denotes for
T22736 1673-1675 JJ denotes WT
T22737 1676-1687 NN denotes lymphocytes
T22738 1688-1691 CC denotes and
T22739 1692-1694 JJ denotes WT
T22740 1695-1704 NN denotes lymphomas
T22741 1704-1705 -COMMA- denotes ,
T22742 1706-1707 NN denotes n
T22743 1708-1709 SYM denotes =
T22744 1710-1712 CD denotes 11
T22745 1713-1716 IN denotes for
T22746 1717-1721 NN denotes LMP1
T22747 1722-1732 JJ denotes transgenic
T22748 1733-1744 NN denotes lymphocytes
T22749 1744-1745 -COMMA- denotes ,
T22750 1746-1749 CC denotes and
T22751 1750-1751 NN denotes n
T22752 1752-1753 SYM denotes =
T22753 1754-1756 CD denotes 13
T22754 1757-1760 IN denotes for
T22755 1761-1765 NN denotes LMP1
T22756 1766-1776 JJ denotes transgenic
T22757 1777-1786 NN denotes lymphomas
T22758 1788-1789 -LRB- denotes (
T22759 1789-1790 NN denotes B
T22760 1790-1791 -RRB- denotes )
T22761 1792-1795 NN denotes EMA
T22762 1796-1805 NN denotes exclusion
T22763 1806-1808 IN denotes of
T22764 1809-1814 JJ denotes CD19+
T22765 1815-1820 JJ denotes gated
T22766 1821-1832 NN denotes splenocytes
T22767 1833-1837 IN denotes from
T22768 1838-1840 NN denotes WT
T22769 1841-1844 CC denotes and
T22770 1845-1849 NN denotes LMP1
T22771 1850-1860 JJ denotes transgenic
T22772 1861-1865 NN denotes mice
T22773 1866-1873 VB denotes showing
T22774 1874-1884 NN denotes percentage
T22775 1885-1887 IN denotes of
T22776 1888-1894 JJ denotes viable
T22777 1895-1896 NN denotes B
T22778 1897-1902 NN denotes cells
T22779 1903-1911 VB denotes cultured
T22780 1912-1916 IN denotes with
T22781 1917-1918 -LRB- denotes (
T22782 1918-1923 JJ denotes white
T22783 1924-1928 NN denotes bars
T22784 1928-1929 -RRB- denotes )
T22785 1930-1932 CC denotes or
T22786 1933-1940 IN denotes without
T22787 1941-1942 -LRB- denotes (
T22788 1942-1947 JJ denotes black
T22789 1948-1952 NN denotes bars
T22790 1952-1953 -RRB- denotes )
T22791 1954-1957 NN denotes IL4
T22792 1958-1961 IN denotes for
T22793 1962-1963 CD denotes 2
T22794 1964-1965 NN denotes d
T22795 1967-1968 -LRB- denotes (
T22796 1968-1969 NN denotes C
T22797 1969-1970 -RRB- denotes )
T22798 1971-1975 NN denotes Flow
T22799 1976-1985 NN denotes cytometry
T22800 1986-1994 NN denotes analysis
T22801 1995-1998 IN denotes for
T22802 1999-2011 JJ denotes incorporated
T22803 2012-2016 NNP denotes BrdU
T22804 2017-2019 IN denotes in
T22805 2020-2022 NN denotes WT
T22806 2023-2026 CC denotes and
T22807 2027-2031 NN denotes LMP1
T22808 2032-2042 JJ denotes transgenic
T22809 2043-2051 NN denotes lymphoma
T22810 2052-2057 NN denotes cells
T22811 2058-2066 VB denotes cultured
T22812 2067-2071 IN denotes with
T22813 2072-2074 CC denotes or
T22814 2075-2082 IN denotes without
T22815 2083-2086 NN denotes IL4
T22816 2087-2090 IN denotes for
T22817 2091-2092 CD denotes 2
T22818 2093-2094 NN denotes d
T22819 2096-2101 VB denotes Shown
T22820 2102-2105 VB denotes are
T22821 2106-2109 DT denotes the
T22822 2110-2117 NN denotes results
T22823 2118-2122 IN denotes from
T22824 2123-2125 JJ denotes WT
T22825 2126-2134 NN denotes lymphoma
T22826 2135-2136 CD denotes 1
T22827 2137-2140 CC denotes and
T22828 2141-2145 NN denotes LMP1
T22829 2146-2156 JJ denotes transgenic
T22830 2157-2165 NN denotes lymphoma
T22831 2166-2167 CD denotes 2
T22832 2169-2180 NN denotes Percentages
T22833 2181-2183 IN denotes of
T22834 2184-2189 NN denotes cells
T22835 2190-2192 IN denotes in
T22836 2193-2197 DT denotes each
T22837 2198-2206 NN denotes quadrant
T22838 2207-2210 VB denotes are
T22839 2211-2216 VB denotes shown
T25510 3852-3859 NN denotes Summary
T25511 3860-3862 IN denotes of
T25512 3863-3871 NN denotes Analysis
T25513 3872-3881 NNP denotes Performed
T25514 3882-3884 IN denotes on
T25515 3885-3894 NNP denotes Wild-Type
T25516 3895-3898 CC denotes and
T25517 3899-3903 NN denotes LMP1
T25518 3904-3914 JJ denotes Transgenic
T25519 3915-3924 NN denotes Lymphomas
R4323 T5547 T5548 arg1Of LMP1,Promotes
R4324 T5551 T5552 arg1Of Survival,and
R4325 T5552 T5548 arg2Of and,Promotes
R4326 T5552 T5549 arg1Of and,B
R4327 T5552 T5550 arg1Of and,Cell
R4328 T5552 T5554 arg1Of and,In
R4329 T5553 T5552 arg2Of Proliferation,and
R4330 T5555 T5554 arg2Of Vitro,In
R4331 T5559 T5556 arg1Of cultures,Primary
R4332 T5559 T5557 arg1Of cultures,B
R4333 T5559 T5558 arg1Of cultures,cell
R4334 T5559 T5560 arg1Of cultures,can
R4335 T5559 T5561 arg1Of cultures,be
R4336 T5559 T5562 arg2Of cultures,maintained
R4337 T5562 T5560 arg2Of maintained,can
R4338 T5562 T5561 arg2Of maintained,be
R4339 T5562 T5563 arg1Of maintained,through
R4340 T5562 T5570 arg1Of maintained,[
R4341 T5565 T5566 arg1Of ligation,and
R4342 T5566 T5563 arg2Of and,through
R4343 T5566 T5564 arg1Of and,CD40
R4344 T5566 T5568 arg1Of and,with
R4345 T5567 T5566 arg2Of supplementation,and
R4346 T5569 T5568 arg2Of IL4,with
R4347 T5571 T5570 arg2Of 32,[
R4348 T5572 T5570 arg3Of ],[
R4349 T5574 T5573 arg1Of investigate,To
R4350 T5576 T5577 arg1Of LMP1,affects
R4351 T5577 T5574 arg2Of affects,investigate
R4352 T5577 T5575 arg1Of affects,whether
R4353 T5581 T5582 arg1Of survival,and
R4354 T5582 T5577 arg2Of and,affects
R4355 T5582 T5578 arg1Of and,primary
R4356 T5582 T5579 arg1Of and,B
R4357 T5582 T5580 arg1Of and,cell
R4358 T5583 T5582 arg2Of proliferation,and
R4359 T5585 T5574 arg1Of splenocytes,investigate
R4360 T5585 T5586 arg1Of splenocytes,were
R4361 T5585 T5587 arg2Of splenocytes,cultured
R4362 T5585 T5596 arg2Of splenocytes,analyzed
R4363 T5587 T5588 arg1Of cultured,in
R4364 T5587 T5595 arg1Of cultured,and
R4365 T5590 T5591 arg1Of presence,or
R4366 T5591 T5588 arg2Of or,in
R4367 T5591 T5589 arg1Of or,the
R4368 T5591 T5593 arg1Of or,of
R4369 T5592 T5591 arg2Of absence,or
R4370 T5594 T5593 arg2Of IL4,of
R4371 T5595 T5573 modOf and,To
R4372 T5595 T5584 arg1Of and,","
R4373 T5595 T5586 arg2Of and,were
R4374 T5596 T5595 arg2Of analyzed,and
R4375 T5596 T5597 arg1Of analyzed,by
R4376 T5596 T5599 arg1Of analyzed,as
R4377 T5596 T5603 arg1Of analyzed,","
R4378 T5596 T5611 arg1Of analyzed,for
R4379 T5596 T5615 arg1Of analyzed,by
R4380 T5598 T5597 arg2Of MTS,by
R4381 T5602 T5599 arg2Of marker,as
R4382 T5602 T5600 arg1Of marker,a
R4383 T5602 T5601 arg1Of marker,metabolic
R4384 T5606 T5605 arg1Of monoazide,ethidium
R4385 T5606 T5607 arg1Of monoazide,(
R4386 T5608 T5607 arg2Of EMA,(
R4387 T5609 T5607 arg3Of ),(
R4388 T5610 T5596 arg1Of exclusion,analyzed
R4389 T5610 T5604 arg2Of exclusion,by
R4390 T5610 T5606 arg1Of exclusion,monoazide
R4391 T5611 T5614 arg1Of for,and
R4392 T5612 T5611 arg2Of viability,for
R4393 T5614 T5613 arg1Of and,","
R4394 T5615 T5614 arg2Of by,and
R4395 T5618 T5617 arg2Of BrdU,(
R4396 T5619 T5617 arg3Of ),(
R4397 T5620 T5615 arg2Of incorporation,by
R4398 T5620 T5616 arg1Of incorporation,5-bromo-2′-deoxy-uridine
R4399 T5620 T5617 arg1Of incorporation,(
R4400 T5620 T5621 arg1Of incorporation,for
R4401 T5622 T5621 arg2Of proliferation,for
R4402 T5626 T5623 arg2Of assay,In
R4403 T5626 T5624 arg1Of assay,the
R4404 T5626 T5625 arg1Of assay,MTS
R4405 T5629 T5628 arg2Of expected,as
R4406 T5631 T5632 arg1Of splenocytes,from
R4407 T5631 T5635 arg1Of splenocytes,did
R4408 T5631 T5637 arg1Of splenocytes,survive
R4409 T5634 T5632 arg2Of mice,from
R4410 T5634 T5633 arg1Of mice,wild-type
R4411 T5637 T5623 arg1Of survive,In
R4412 T5637 T5627 arg1Of survive,","
R4413 T5637 T5628 arg1Of survive,as
R4414 T5637 T5630 arg1Of survive,","
R4415 T5637 T5635 arg2Of survive,did
R4416 T5637 T5636 arg1Of survive,not
R4417 T5637 T5639 arg1Of survive,with
R4418 T5639 T5638 arg1Of with,even
R4419 T5641 T5639 arg2Of addition,with
R4420 T5641 T5640 arg1Of addition,the
R4421 T5641 T5642 arg1Of addition,of
R4422 T5641 T5645 arg1Of addition,to
R4423 T5643 T5642 arg2Of IL4,of
R4424 T5645 T5644 arg1Of to,due
R4425 T5647 T5645 arg2Of lack,to
R4426 T5647 T5646 arg1Of lack,a
R4427 T5647 T5648 arg1Of lack,of
R4428 T5650 T5648 arg2Of ligation,of
R4429 T5650 T5649 arg1Of ligation,CD40
R4430 T5650 T5651 arg1Of ligation,(
R4431 T5653 T5651 arg2Of 3A,(
R4432 T5653 T5652 arg1Of 3A,Figure
R4433 T5654 T5651 arg3Of ),(
R4434 T5656 T5655 arg2Of contrast,In
R4435 T5659 T5658 arg1Of splenocytes,LMP1
R4436 T5659 T5660 arg1Of splenocytes,had
R4437 T5659 T5661 arg1Of splenocytes,increased
R4438 T5661 T5655 arg1Of increased,In
R4439 T5661 T5657 arg1Of increased,","
R4440 T5661 T5660 arg2Of increased,had
R4441 T5661 T5664 arg1Of increased,in
R4442 T5662 T5661 arg2Of metabolism,increased
R4443 T5664 T5663 arg1Of in,even
R4444 T5666 T5664 arg2Of absence,in
R4445 T5666 T5665 arg1Of absence,the
R4446 T5666 T5667 arg1Of absence,of
R4447 T5666 T5669 arg1Of absence,","
R4448 T5666 T5670 arg1Of absence,which
R4449 T5666 T5671 arg1Of absence,was
R4450 T5666 T5673 arg2Of absence,enhanced
R4451 T5668 T5667 arg2Of IL4,of
R4452 T5673 T5671 arg2Of enhanced,was
R4453 T5673 T5672 arg1Of enhanced,further
R4454 T5673 T5674 arg1Of enhanced,upon
R4455 T5675 T5674 arg2Of addition,upon
R4456 T5675 T5676 arg1Of addition,of
R4457 T5677 T5676 arg2Of IL4,of
R4458 T5678 T5679 arg1Of Wild-type,and
R4459 T5679 T5684 arg1Of and,had
R4460 T5683 T5679 arg2Of cells,and
R4461 T5683 T5680 arg1Of cells,LMP1
R4462 T5683 T5681 arg1Of cells,transgenic
R4463 T5683 T5682 arg1Of cells,lymphoma
R4464 T5684 T5691 arg1Of had,in
R4465 T5686 T5684 arg2Of levels,had
R4466 T5686 T5685 arg1Of levels,high
R4467 T5686 T5687 arg1Of levels,of
R4468 T5689 T5687 arg2Of activity,of
R4469 T5689 T5688 arg1Of activity,MTS
R4470 T5691 T5690 arg1Of in,even
R4471 T5693 T5691 arg2Of absence,in
R4472 T5693 T5692 arg1Of absence,the
R4473 T5693 T5694 arg1Of absence,of
R4474 T5695 T5694 arg2Of IL4,of
R4475 T5695 T5696 arg1Of IL4,(
R4476 T5698 T5696 arg2Of 3A,(
R4477 T5698 T5697 arg1Of 3A,Figure
R4478 T5699 T5696 arg3Of ),(
R4479 T5704 T5700 arg1Of cells,The
R4480 T5704 T5701 arg1Of cells,LMP1
R4481 T5704 T5702 arg1Of cells,transgenic
R4482 T5704 T5703 arg1Of cells,lymphoma
R4483 T5704 T5705 arg1Of cells,had
R4484 T5704 T5717 arg1Of cells,were
R4485 T5704 T5721 arg1Of cells,higher
R4486 T5705 T5716 arg1Of had,and
R4487 T5707 T5706 arg1Of 4-fold,approximately
R4488 T5708 T5707 arg1Of higher,4-fold
R4489 T5710 T5705 arg2Of activity,had
R4490 T5710 T5708 arg1Of activity,higher
R4491 T5710 T5709 arg1Of activity,MTS
R4492 T5710 T5711 arg1Of activity,than
R4493 T5715 T5711 arg2Of lymphocytes,than
R4494 T5715 T5712 arg1Of lymphocytes,the
R4495 T5715 T5713 arg1Of lymphocytes,normal
R4496 T5715 T5714 arg1Of lymphocytes,transgenic
R4497 T5717 T5716 arg2Of were,and
R4498 T5717 T5719 arg1Of were,least
R4499 T5719 T5718 arg1Of least,at
R4500 T5721 T5717 arg2Of higher,were
R4501 T5721 T5720 arg1Of higher,2-fold
R4502 T5721 T5722 arg1Of higher,than
R4503 T5725 T5722 arg2Of lymphoma,than
R4504 T5725 T5723 arg1Of lymphoma,the
R4505 T5725 T5724 arg1Of lymphoma,control
R4506 T5728 T5727 arg1Of published,previously
R4507 T5730 T5728 arg1Of lymphoma,published
R4508 T5730 T5729 arg1Of lymphoma,","
R4509 T5730 T5732 arg1Of lymphoma,develops
R4510 T5732 T5726 arg1Of develops,As
R4511 T5732 T5731 arg1Of develops,usually
R4512 T5732 T5733 arg1Of develops,in
R4513 T5732 T5735 arg1Of develops,over
R4514 T5732 T5740 arg1Of develops,and
R4515 T5734 T5733 arg2Of mice,in
R4516 T5737 T5735 arg2Of mo,over
R4517 T5737 T5736 arg1Of mo,12
R4518 T5737 T5738 arg1Of mo,of
R4519 T5739 T5738 arg2Of age,of
R4520 T5742 T5741 arg1Of mice,all
R4521 T5742 T5743 arg1Of mice,are
R4522 T5742 T5744 arg2Of mice,sacrificed
R4523 T5744 T5740 arg2Of sacrificed,and
R4524 T5744 T5743 arg2Of sacrificed,are
R4525 T5744 T5745 arg1Of sacrificed,by
R4526 T5747 T5745 arg2Of mo,by
R4527 T5747 T5746 arg1Of mo,18–20
R4528 T5749 T5748 arg1Of ages,The
R4529 T5749 T5750 arg1Of ages,of
R4530 T5749 T5758 arg1Of ages,ranged
R4531 T5753 T5750 arg2Of mice,of
R4532 T5753 T5751 arg1Of mice,the
R4533 T5753 T5752 arg1Of mice,transgenic
R4534 T5753 T5754 arg1Of mice,with
R4535 T5753 T5756 arg1Of mice,without
R4536 T5754 T5755 arg1Of with,or
R4537 T5756 T5755 arg2Of without,or
R4538 T5757 T5754 arg2Of lymphoma,with
R4539 T5757 T5756 arg2Of lymphoma,without
R4540 T5758 T5764 arg1Of ranged,old
R4541 T5760 T5761 arg1Of 6,and
R4542 T5761 T5759 arg1Of and,between
R4543 T5762 T5761 arg2Of 20,and
R4544 T5763 T5760 arg1Of mo,6
R4545 T5763 T5762 arg1Of mo,20
R4546 T5764 T5763 arg1Of old,mo
R4547 T5765 T5766 arg1Of There,was
R4548 T5768 T5766 arg2Of correlation,was
R4549 T5768 T5767 arg1Of correlation,no
R4550 T5768 T5769 arg1Of correlation,between
R4551 T5770 T5771 arg1Of age,and
R4552 T5771 T5769 arg2Of and,between
R4553 T5773 T5771 arg2Of activity,and
R4554 T5773 T5772 arg1Of activity,MTS
R4555 T5775 T5774 arg1Of exclusion,EMA
R4556 T5775 T5776 arg1Of exclusion,of
R4557 T5775 T5790 arg1Of exclusion,indicated
R4558 T5780 T5776 arg2Of cells,of
R4559 T5780 T5777 arg1Of cells,CD19+
R4560 T5780 T5778 arg2Of cells,gated
R4561 T5780 T5779 arg1Of cells,B
R4562 T5780 T5781 arg2Of cells,prepared
R4563 T5781 T5782 arg1Of prepared,from
R4564 T5784 T5785 arg1Of wild-type,and
R4565 T5786 T5785 arg2Of two,and
R4566 T5789 T5782 arg2Of mice,from
R4567 T5789 T5783 arg1Of mice,two
R4568 T5789 T5784 arg1Of mice,wild-type
R4569 T5789 T5786 arg1Of mice,two
R4570 T5789 T5787 arg1Of mice,LMP1
R4571 T5789 T5788 arg1Of mice,transgenic
R4572 T5793 T5790 arg2Of increase,indicated
R4573 T5793 T5791 arg1Of increase,a
R4574 T5793 T5792 arg1Of increase,2-fold
R4575 T5793 T5794 arg1Of increase,in
R4576 T5793 T5796 arg1Of increase,in
R4577 T5795 T5794 arg2Of viability,in
R4578 T5800 T5796 arg2Of lymphocytes,in
R4579 T5800 T5797 arg1Of lymphocytes,the
R4580 T5800 T5798 arg1Of lymphocytes,LMP1
R4581 T5800 T5799 arg1Of lymphocytes,transgenic
R4582 T5800 T5801 arg1Of lymphocytes,compared
R4583 T5802 T5801 arg2Of to,compared
R4584 T5804 T5802 arg2Of lymphocytes,to
R4585 T5804 T5803 arg1Of lymphocytes,wild-type
R4586 T5806 T5805 arg1Of examples,Two
R4587 T5806 T5807 arg1Of examples,of
R4588 T5806 T5812 arg1Of examples,had
R4589 T5811 T5807 arg2Of cells,of
R4590 T5811 T5808 arg1Of cells,LMP1
R4591 T5811 T5809 arg1Of cells,transgenic
R4592 T5811 T5810 arg1Of cells,lymphoma
R4593 T5814 T5813 arg1Of increased,greatly
R4594 T5815 T5812 arg2Of viability,had
R4595 T5815 T5814 arg1Of viability,increased
R4596 T5815 T5816 arg1Of viability,that
R4597 T5815 T5817 arg1Of viability,was
R4598 T5815 T5819 arg2Of viability,increased
R4599 T5819 T5817 arg2Of increased,was
R4600 T5819 T5818 arg1Of increased,not
R4601 T5819 T5823 arg1Of increased,","
R4602 T5819 T5824 modOf increased,indicating
R4603 T5822 T5819 arg1Of treatment,increased
R4604 T5822 T5820 arg2Of treatment,by
R4605 T5822 T5821 arg1Of treatment,IL4
R4606 T5828 T5826 arg1Of cells,the
R4607 T5828 T5827 arg1Of cells,lymphoma
R4608 T5828 T5829 arg1Of cells,are
R4609 T5828 T5830 arg1Of cells,independent
R4610 T5829 T5824 arg2Of are,indicating
R4611 T5829 T5825 arg1Of are,that
R4612 T5830 T5829 arg2Of independent,are
R4613 T5830 T5831 arg1Of independent,of
R4614 T5833 T5831 arg2Of co-stimulation,of
R4615 T5833 T5832 arg1Of co-stimulation,IL4
R4616 T5833 T5834 arg1Of co-stimulation,(
R4617 T5836 T5834 arg2Of 3B,(
R4618 T5836 T5835 arg1Of 3B,Figure
R4619 T5837 T5834 arg3Of ),(
R4620 T5838 T5839 arg1Of Enhancement,in
R4621 T5838 T5842 arg1Of Enhancement,was
R4622 T5838 T5843 arg2Of Enhancement,observed
R4623 T5841 T5839 arg2Of activity,in
R4624 T5841 T5840 arg1Of activity,MTS
R4625 T5843 T5842 arg2Of observed,was
R4626 T5843 T5844 arg1Of observed,in
R4627 T5843 T5849 arg1Of observed,by
R4628 T5843 T5854 arg1Of observed,;
R4629 T5848 T5844 arg2Of cells,in
R4630 T5848 T5845 arg1Of cells,LMP1
R4631 T5848 T5846 arg1Of cells,transgenic
R4632 T5848 T5847 arg1Of cells,lymphoma
R4633 T5851 T5849 arg2Of addition,by
R4634 T5851 T5850 arg1Of addition,the
R4635 T5851 T5852 arg1Of addition,of
R4636 T5853 T5852 arg2Of IL4,of
R4637 T5858 T5857 arg1Of exclusion,EMA
R4638 T5858 T5859 arg1Of exclusion,did
R4639 T5858 T5861 arg1Of exclusion,reveal
R4640 T5861 T5854 arg2Of reveal,;
R4641 T5861 T5855 arg1Of reveal,however
R4642 T5861 T5856 arg1Of reveal,","
R4643 T5861 T5859 arg2Of reveal,did
R4644 T5861 T5860 arg1Of reveal,not
R4645 T5864 T5861 arg2Of increase,reveal
R4646 T5864 T5862 arg1Of increase,a
R4647 T5864 T5863 arg1Of increase,similar
R4648 T5865 T5866 arg1Of This,could
R4649 T5865 T5867 arg1Of This,reflect
R4650 T5867 T5866 arg2Of reflect,could
R4651 T5869 T5867 arg2Of difference,reflect
R4652 T5869 T5868 arg1Of difference,a
R4653 T5869 T5870 arg1Of difference,for
R4654 T5872 T5870 arg2Of requirement,for
R4655 T5872 T5871 arg1Of requirement,IL4
R4656 T5872 T5873 arg1Of requirement,in
R4657 T5876 T5873 arg2Of activity,in
R4658 T5876 T5874 arg1Of activity,the
R4659 T5876 T5875 arg1Of activity,metabolic
R4660 T5876 T5877 arg1Of activity,versus
R4661 T5879 T5877 arg2Of viability,versus
R4662 T5879 T5878 arg1Of viability,the
R4663 T5879 T5880 arg1Of viability,of
R4664 T5884 T5880 arg2Of cells,of
R4665 T5884 T5881 arg1Of cells,LMP1
R4666 T5884 T5882 arg1Of cells,transgenic
R4667 T5884 T5883 arg1Of cells,lymphoma
R4668 T5886 T5887 arg1Of expression,of
R4669 T5886 T5889 arg1Of expression,could
R4670 T5886 T5890 arg1Of expression,enhance
R4671 T5888 T5887 arg2Of LMP1,of
R4672 T5890 T5885 arg2Of enhance,Although
R4673 T5890 T5889 arg2Of enhance,could
R4674 T5891 T5890 arg2Of survival,enhance
R4675 T5891 T5892 arg1Of survival,of
R4676 T5895 T5892 arg2Of lymphocytes,of
R4677 T5895 T5893 arg1Of lymphocytes,non-malignant
R4678 T5895 T5894 arg1Of lymphocytes,primary
R4679 T5898 T5897 arg1Of incorporation,BrdU
R4680 T5898 T5899 arg1Of incorporation,revealed
R4681 T5899 T5885 arg1Of revealed,Although
R4682 T5899 T5896 arg1Of revealed,","
R4683 T5902 T5901 arg1Of expression,LMP1
R4684 T5902 T5903 arg1Of expression,alone
R4685 T5902 T5904 arg1Of expression,was
R4686 T5902 T5906 arg1Of expression,sufficient
R4687 T5904 T5899 arg2Of was,revealed
R4688 T5904 T5900 arg1Of was,that
R4689 T5904 T5905 arg1Of was,not
R4690 T5904 T5907 modOf was,to
R4691 T5906 T5904 arg2Of sufficient,was
R4692 T5908 T5907 arg1Of induce,to
R4693 T5908 T5910 arg1Of induce,in
R4694 T5909 T5908 arg2Of proliferation,induce
R4695 T5911 T5910 arg2Of culture,in
R4696 T5911 T5912 arg1Of culture,(
R4697 T5914 T5912 arg2Of data,(
R4698 T5914 T5913 arg1Of data,unpublished
R4699 T5915 T5912 arg3Of ),(
R4700 T5918 T5916 arg1Of cells,Only
R4701 T5918 T5917 arg1Of cells,lymphoma
R4702 T5918 T5919 arg1Of cells,had
R4703 T5921 T5919 arg2Of levels,had
R4704 T5921 T5920 arg1Of levels,detectable
R4705 T5921 T5922 arg1Of levels,of
R4706 T5924 T5922 arg2Of incorporation,of
R4707 T5924 T5923 arg1Of incorporation,BrdU
R4708 T5924 T5925 arg2Of incorporation,detected
R4709 T5928 T5925 arg1Of cytometry,detected
R4710 T5928 T5926 arg2Of cytometry,by
R4711 T5928 T5927 arg1Of cytometry,flow
R4712 T5928 T5929 arg1Of cytometry,(
R4713 T5931 T5929 arg2Of 3C,(
R4714 T5931 T5930 arg1Of 3C,Figure
R4715 T5932 T5929 arg3Of ),(
R4716 T5937 T5935 arg1Of cells,LMP1
R4717 T5937 T5936 arg1Of cells,lymphoma
R4718 T5937 T5938 arg1Of cells,had
R4719 T5938 T5933 arg1Of had,Interestingly
R4720 T5938 T5934 arg1Of had,","
R4721 T5938 T5944 arg1Of had,in
R4722 T5940 T5939 arg1Of higher,significantly
R4723 T5941 T5938 arg2Of levels,had
R4724 T5941 T5940 arg1Of levels,higher
R4725 T5941 T5942 arg1Of levels,of
R4726 T5943 T5942 arg2Of proliferation,of
R4727 T5944 T5946 arg1Of in,to
R4728 T5945 T5944 arg2Of comparison,in
R4729 T5949 T5944 arg3Of lymphoma,in
R4730 T5949 T5947 arg1Of lymphoma,the
R4731 T5949 T5948 arg1Of lymphoma,spontaneous
R4732 T5949 T5950 arg1Of lymphoma,that
R4733 T5949 T5951 arg1Of lymphoma,developed
R4734 T5951 T5952 arg1Of developed,in
R4735 T5955 T5952 arg2Of littermate,in
R4736 T5955 T5953 arg1Of littermate,an
R4737 T5955 T5954 arg1Of littermate,LMP1-negative
R4738 T5955 T5956 arg1Of littermate,(
R4739 T5958 T5957 arg1Of %,25
R4740 T5961 T5956 arg2Of %,(
R4741 T5961 T5958 arg1Of %,%
R4742 T5961 T5959 arg1Of %,versus
R4743 T5961 T5960 arg1Of %,4
R4744 T5962 T5956 arg3Of ),(
R4745 T5965 T5963 arg1Of level,This
R4746 T5965 T5964 arg1Of level,higher
R4747 T5965 T5966 arg1Of level,of
R4748 T5965 T5968 arg1Of level,was
R4749 T5965 T5969 arg2Of level,observed
R4750 T5967 T5966 arg2Of proliferation,of
R4751 T5969 T5968 arg2Of observed,was
R4752 T5969 T5970 arg1Of observed,in
R4753 T5969 T5995 arg1Of observed,","
R4754 T5969 T5996 modOf observed,suggesting
R4755 T5971 T5970 arg2Of lymphomas,in
R4756 T5971 T5972 arg1Of lymphomas,that
R4757 T5971 T5973 arg1Of lymphomas,express
R4758 T5978 T5975 arg1Of 1,high
R4759 T5978 T5976 arg2Of 1,(
R4760 T5978 T5977 arg1Of 1,Table
R4761 T5978 T5979 arg1Of 1,","
R4762 T5978 T5984 arg1Of 1,and
R4763 T5980 T5981 arg1Of LMP1-L2,and
R4764 T5981 T5979 arg2Of and,","
R4765 T5982 T5981 arg2Of LMP1-L3,and
R4766 T5983 T5976 arg3Of ),(
R4767 T5984 T5973 arg2Of and,express
R4768 T5984 T5974 arg1Of and,both
R4769 T5985 T5986 arg1Of low,(
R4770 T5988 T5986 arg2Of 1,(
R4771 T5988 T5987 arg1Of 1,Table
R4772 T5988 T5989 arg1Of 1,","
R4773 T5990 T5989 arg2Of LMP1-L5,","
R4774 T5991 T5986 arg3Of ),(
R4775 T5992 T5984 arg2Of levels,and
R4776 T5992 T5985 arg1Of levels,low
R4777 T5992 T5993 arg1Of levels,of
R4778 T5994 T5993 arg2Of LMP1,of
R4779 T6000 T5998 arg1Of amounts,even
R4780 T6000 T5999 arg1Of amounts,small
R4781 T6000 T6001 arg1Of amounts,of
R4782 T6000 T6003 arg1Of amounts,is
R4783 T6000 T6004 arg1Of amounts,sufficient
R4784 T6002 T6001 arg2Of LMP1,of
R4785 T6003 T5996 arg2Of is,suggesting
R4786 T6003 T5997 arg1Of is,that
R4787 T6004 T6003 arg2Of sufficient,is
R4788 T6006 T6004 arg2Of induce,sufficient
R4789 T6006 T6005 arg1Of induce,to
R4790 T6006 T6009 arg1Of induce,in
R4791 T6008 T6006 arg2Of effects,induce
R4792 T6008 T6007 arg1Of effects,dramatic
R4793 T6010 T6009 arg2Of proliferation,in
R4794 T6012 T6011 arg1Of level,The
R4795 T6012 T6013 arg1Of level,of
R4796 T6012 T6015 arg1Of level,was
R4797 T6012 T6017 arg2Of level,enhanced
R4798 T6014 T6013 arg2Of proliferation,of
R4799 T6017 T6015 arg2Of enhanced,was
R4800 T6017 T6016 arg1Of enhanced,not
R4801 T6017 T6018 arg1Of enhanced,upon
R4802 T6017 T6021 arg1Of enhanced,","
R4803 T6020 T6018 arg2Of addition,upon
R4804 T6020 T6019 arg1Of addition,IL4
R4805 T6022 T6017 arg3Of confirming,enhanced
R4806 T6025 T6022 arg2Of independence,confirming
R4807 T6025 T6023 arg1Of independence,the
R4808 T6025 T6024 arg1Of independence,IL4
R4809 T6025 T6026 arg2Of independence,observed
R4810 T6026 T6027 arg1Of observed,in
R4811 T6030 T6027 arg2Of studies,in
R4812 T6030 T6028 arg1Of studies,the
R4813 T6030 T6029 arg1Of studies,viability
R4814 T6030 T6031 arg1Of studies,(
R4815 T6033 T6031 arg2Of 3C,(
R4816 T6033 T6032 arg1Of 3C,Figure
R4817 T6033 T6034 arg1Of 3C,;
R4818 T6035 T6034 arg2Of Table1,;
R4819 T6036 T6031 arg3Of ),(
R17674 T22664 T22665 arg1Of LMP1,Promotes
R17675 T22668 T22669 arg1Of Survival,and
R17676 T22669 T22665 arg2Of and,Promotes
R17677 T22669 T22666 arg1Of and,B
R17678 T22669 T22667 arg1Of and,Cell
R17679 T22669 T22671 arg1Of and,In
R17680 T22670 T22669 arg2Of Proliferation,and
R17681 T22672 T22671 arg2Of Vitro,In
R17682 T22674 T22673 arg2Of A,(
R17683 T22675 T22673 arg3Of ),(
R17684 T22677 T22673 arg1Of assay,(
R17685 T22677 T22676 arg1Of assay,MTS
R17686 T22677 T22678 arg1Of assay,of
R17687 T22679 T22678 arg2Of splenocytes,of
R17688 T22679 T22680 arg1Of splenocytes,from
R17689 T22681 T22682 arg1Of WT,and
R17690 T22683 T22682 arg2Of LMP1,and
R17691 T22685 T22680 arg2Of mice,from
R17692 T22685 T22681 arg1Of mice,WT
R17693 T22685 T22683 arg1Of mice,LMP1
R17694 T22685 T22684 arg1Of mice,transgenic
R17695 T22686 T22687 arg1Of Splenocytes,were
R17696 T22686 T22688 arg2Of Splenocytes,cultured
R17697 T22688 T22687 arg2Of cultured,were
R17698 T22688 T22689 arg1Of cultured,in
R17699 T22688 T22704 arg1Of cultured,for
R17700 T22691 T22690 arg1Of presence,the
R17701 T22691 T22692 arg1Of presence,(
R17702 T22691 T22696 arg1Of presence,or
R17703 T22694 T22692 arg2Of bars,(
R17704 T22694 T22693 arg1Of bars,grey
R17705 T22695 T22692 arg3Of ),(
R17706 T22696 T22689 arg2Of or,in
R17707 T22697 T22696 arg2Of absence,or
R17708 T22697 T22698 arg1Of absence,(
R17709 T22697 T22702 arg1Of absence,of
R17710 T22700 T22698 arg2Of bars,(
R17711 T22700 T22699 arg1Of bars,black
R17712 T22701 T22698 arg3Of ),(
R17713 T22703 T22702 arg2Of IL4,of
R17714 T22706 T22704 arg2Of d,for
R17715 T22706 T22705 arg1Of d,3
R17716 T22708 T22707 arg1Of results,The
R17717 T22708 T22709 arg1Of results,are
R17718 T22713 T22710 arg1Of SEM,the
R17719 T22713 T22711 arg1Of SEM,mean
R17720 T22713 T22712 arg1Of SEM,±
R17721 T22713 T22714 arg1Of SEM,of
R17722 T22713 T22717 arg1Of SEM,averaged
R17723 T22716 T22714 arg2Of samples,of
R17724 T22716 T22715 arg1Of samples,triplicate
R17725 T22717 T22709 arg2Of averaged,are
R17726 T22717 T22718 arg1Of averaged,from
R17727 T22720 T22718 arg2Of mice,from
R17728 T22720 T22719 arg1Of mice,multiple
R17729 T22720 T22721 arg1Of mice,where
R17730 T22724 T22722 arg1Of number,“n”
R17731 T22724 T22723 arg1Of number,the
R17732 T22724 T22725 arg1Of number,of
R17733 T22724 T22728 arg1Of number,is
R17734 T22724 T22730 arg1Of number,follows
R17735 T22726 T22725 arg2Of mice,of
R17736 T22726 T22727 arg2Of mice,analyzed
R17737 T22730 T22721 arg2Of follows,where
R17738 T22730 T22728 arg2Of follows,is
R17739 T22730 T22729 arg1Of follows,as
R17740 T22730 T22731 arg1Of follows,:
R17741 T22732 T22733 arg1Of n,=
R17742 T22732 T22750 arg1Of n,and
R17743 T22733 T22734 arg1Of =,2
R17744 T22733 T22735 arg1Of =,for
R17745 T22737 T22736 arg1Of lymphocytes,WT
R17746 T22737 T22738 arg1Of lymphocytes,and
R17747 T22738 T22735 arg2Of and,for
R17748 T22738 T22741 arg1Of and,","
R17749 T22740 T22738 arg2Of lymphomas,and
R17750 T22740 T22739 arg1Of lymphomas,WT
R17751 T22742 T22741 arg2Of n,","
R17752 T22742 T22745 arg1Of n,for
R17753 T22743 T22744 arg1Of =,11
R17754 T22745 T22743 arg1Of for,=
R17755 T22748 T22745 arg2Of lymphocytes,for
R17756 T22748 T22746 arg1Of lymphocytes,LMP1
R17757 T22748 T22747 arg1Of lymphocytes,transgenic
R17758 T22750 T22730 arg2Of and,follows
R17759 T22750 T22749 arg1Of and,","
R17760 T22751 T22750 arg2Of n,and
R17761 T22751 T22752 arg1Of n,=
R17762 T22752 T22753 arg1Of =,13
R17763 T22752 T22754 arg1Of =,for
R17764 T22757 T22754 arg2Of lymphomas,for
R17765 T22757 T22755 arg1Of lymphomas,LMP1
R17766 T22757 T22756 arg1Of lymphomas,transgenic
R17767 T22759 T22758 arg2Of B,(
R17768 T22760 T22758 arg3Of ),(
R17769 T22762 T22758 arg1Of exclusion,(
R17770 T22762 T22761 arg1Of exclusion,EMA
R17771 T22762 T22763 arg1Of exclusion,of
R17772 T22762 T22767 arg1Of exclusion,from
R17773 T22766 T22763 arg2Of splenocytes,of
R17774 T22766 T22764 arg1Of splenocytes,CD19+
R17775 T22766 T22765 arg1Of splenocytes,gated
R17776 T22768 T22769 arg1Of WT,and
R17777 T22770 T22769 arg2Of LMP1,and
R17778 T22772 T22767 arg2Of mice,from
R17779 T22772 T22768 arg1Of mice,WT
R17780 T22772 T22770 arg1Of mice,LMP1
R17781 T22772 T22771 arg1Of mice,transgenic
R17782 T22772 T22773 arg1Of mice,showing
R17783 T22774 T22773 arg2Of percentage,showing
R17784 T22774 T22775 arg1Of percentage,of
R17785 T22778 T22775 arg2Of cells,of
R17786 T22778 T22776 arg1Of cells,viable
R17787 T22778 T22777 arg1Of cells,B
R17788 T22778 T22779 arg2Of cells,cultured
R17789 T22779 T22780 arg1Of cultured,with
R17790 T22779 T22786 arg1Of cultured,without
R17791 T22780 T22785 arg1Of with,or
R17792 T22783 T22780 arg2Of bars,with
R17793 T22783 T22781 arg2Of bars,(
R17794 T22783 T22782 arg1Of bars,white
R17795 T22784 T22781 arg3Of ),(
R17796 T22786 T22785 arg2Of without,or
R17797 T22789 T22787 arg2Of bars,(
R17798 T22789 T22788 arg1Of bars,black
R17799 T22790 T22787 arg3Of ),(
R17800 T22791 T22786 arg2Of IL4,without
R17801 T22791 T22787 arg1Of IL4,(
R17802 T22791 T22792 arg1Of IL4,for
R17803 T22794 T22792 arg2Of d,for
R17804 T22794 T22793 arg1Of d,2
R17805 T22796 T22795 arg2Of C,(
R17806 T22797 T22795 arg3Of ),(
R17807 T22800 T22795 arg1Of analysis,(
R17808 T22800 T22798 arg1Of analysis,Flow
R17809 T22800 T22799 arg1Of analysis,cytometry
R17810 T22800 T22801 arg1Of analysis,for
R17811 T22800 T22804 arg1Of analysis,in
R17812 T22803 T22801 arg2Of BrdU,for
R17813 T22803 T22802 arg1Of BrdU,incorporated
R17814 T22805 T22806 arg1Of WT,and
R17815 T22807 T22806 arg2Of LMP1,and
R17816 T22810 T22804 arg2Of cells,in
R17817 T22810 T22805 arg1Of cells,WT
R17818 T22810 T22807 arg1Of cells,LMP1
R17819 T22810 T22808 arg1Of cells,transgenic
R17820 T22810 T22809 arg1Of cells,lymphoma
R17821 T22810 T22811 arg2Of cells,cultured
R17822 T22811 T22812 arg1Of cultured,with
R17823 T22811 T22814 arg1Of cultured,without
R17824 T22811 T22816 arg1Of cultured,for
R17825 T22812 T22813 arg1Of with,or
R17826 T22814 T22813 arg2Of without,or
R17827 T22815 T22812 arg2Of IL4,with
R17828 T22815 T22814 arg2Of IL4,without
R17829 T22818 T22816 arg2Of d,for
R17830 T22818 T22817 arg1Of d,2
R17831 T22820 T22819 modOf are,Shown
R17832 T22822 T22819 arg2Of results,Shown
R17833 T22822 T22820 arg1Of results,are
R17834 T22822 T22821 arg1Of results,the
R17835 T22822 T22823 arg1Of results,from
R17836 T22825 T22824 arg1Of lymphoma,WT
R17837 T22825 T22826 arg1Of lymphoma,1
R17838 T22825 T22827 arg1Of lymphoma,and
R17839 T22827 T22823 arg2Of and,from
R17840 T22830 T22827 arg2Of lymphoma,and
R17841 T22830 T22828 arg1Of lymphoma,LMP1
R17842 T22830 T22829 arg1Of lymphoma,transgenic
R17843 T22830 T22831 arg1Of lymphoma,2
R17844 T22832 T22833 arg1Of Percentages,of
R17845 T22832 T22838 arg1Of Percentages,are
R17846 T22832 T22839 arg2Of Percentages,shown
R17847 T22834 T22833 arg2Of cells,of
R17848 T22834 T22835 arg1Of cells,in
R17849 T22837 T22835 arg2Of quadrant,in
R17850 T22837 T22836 arg1Of quadrant,each
R17851 T22839 T22838 arg2Of shown,are
R19769 T25510 T25511 arg1Of Summary,of
R19770 T25510 T25514 arg1Of Summary,on
R19771 T25513 T25511 arg2Of Performed,of
R19772 T25513 T25512 arg1Of Performed,Analysis
R19773 T25515 T25516 arg1Of Wild-Type,and
R19774 T25516 T25514 arg2Of and,on
R19775 T25519 T25516 arg2Of Lymphomas,and
R19776 T25519 T25517 arg1Of Lymphomas,LMP1
R19777 T25519 T25518 arg1Of Lymphomas,Transgenic

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T22851 1315-1319 CD denotes LMP1
T22852 1320-1328 NNP denotes Promotes
T22853 1329-1330 NNP denotes B
T22854 1331-1335 NNP denotes Cell
T22855 1336-1344 NNP denotes Survival
T22856 1345-1348 CC denotes and
T22857 1349-1362 NNP denotes Proliferation
T22858 1363-1365 IN denotes In
T22859 1366-1371 NNP denotes Vitro
T22860 1372-1373 -LRB- denotes (
T22861 1373-1374 NNP denotes A
T22862 1374-1375 -RRB- denotes )
T22863 1376-1379 NNP denotes MTS
T22864 1380-1385 NN denotes assay
T22865 1386-1388 IN denotes of
T22866 1389-1400 NNS denotes splenocytes
T22867 1401-1405 IN denotes from
T22868 1406-1408 NNP denotes WT
T22869 1409-1412 CC denotes and
T22870 1413-1417 NNP denotes LMP1
T22871 1418-1428 JJ denotes transgenic
T22872 1429-1433 NNS denotes mice
T22873 1433-1434 . denotes .
T22874 1435-1446 NNS denotes Splenocytes
T22875 1447-1451 VBD denotes were
T22876 1452-1460 VBN denotes cultured
T22877 1461-1463 IN denotes in
T22878 1464-1467 DT denotes the
T22879 1468-1476 NN denotes presence
T22880 1477-1478 -LRB- denotes (
T22881 1478-1482 NN denotes grey
T22882 1483-1487 NNS denotes bars
T22883 1487-1488 -RRB- denotes )
T22884 1489-1491 CC denotes or
T22885 1492-1499 NN denotes absence
T22886 1500-1501 -LRB- denotes (
T22887 1501-1506 JJ denotes black
T22888 1507-1511 NNS denotes bars
T22889 1511-1512 -RRB- denotes )
T22890 1513-1515 IN denotes of
T22891 1516-1519 NNP denotes IL4
T22892 1520-1523 IN denotes for
T22893 1524-1525 CD denotes 3
T22894 1526-1527 LS denotes d
T22895 1527-1528 . denotes .
T22896 1529-1532 DT denotes The
T22897 1533-1540 NNS denotes results
T22898 1541-1544 VBP denotes are
T22899 1545-1548 DT denotes the
T22900 1549-1553 JJ denotes mean
T22901 1554-1555 NN denotes ±
T22902 1556-1559 NNP denotes SEM
T22903 1560-1562 IN denotes of
T22904 1563-1573 NN denotes triplicate
T22905 1574-1581 NNS denotes samples
T22906 1582-1590 VBD denotes averaged
T22907 1591-1595 IN denotes from
T22908 1596-1604 JJ denotes multiple
T22909 1605-1609 NNS denotes mice
T22910 1610-1615 WRB denotes where
T22911 1617-1618 FW denotes n
T22912 1620-1623 DT denotes the
T22913 1624-1630 NN denotes number
T22914 1631-1633 IN denotes of
T22915 1634-1638 NNS denotes mice
T22916 1639-1647 VBD denotes analyzed
T22917 1648-1650 VBZ denotes is
T22918 1651-1653 IN denotes as
T22919 1654-1661 VBZ denotes follows
T22920 1661-1662 : denotes :
T22921 1663-1664 VB denotes n
T22922 1665-1666 SYM denotes =
T22923 1667-1668 CD denotes 2
T22924 1669-1672 IN denotes for
T22925 1673-1675 NNP denotes WT
T22926 1676-1687 NNS denotes lymphocytes
T22927 1688-1691 CC denotes and
T22928 1692-1694 NNP denotes WT
T22929 1695-1704 NNS denotes lymphomas
T22930 1704-1705 , denotes ,
T22931 1706-1707 VBP denotes n
T22932 1708-1709 SYM denotes =
T22933 1710-1712 CD denotes 11
T22934 1713-1716 IN denotes for
T22935 1717-1721 CD denotes LMP1
T22936 1722-1732 JJ denotes transgenic
T22937 1733-1744 NNS denotes lymphocytes
T22938 1744-1745 , denotes ,
T22939 1746-1749 CC denotes and
T22940 1750-1751 JJ denotes n
T22941 1752-1753 SYM denotes =
T22942 1754-1756 CD denotes 13
T22943 1757-1760 IN denotes for
T22944 1761-1765 CD denotes LMP1
T22945 1766-1776 JJ denotes transgenic
T22946 1777-1786 NNS denotes lymphomas
T22947 1786-1787 . denotes .
T22948 1788-1789 -LRB- denotes (
T22949 1789-1790 NNP denotes B
T22950 1790-1791 -RRB- denotes )
T22951 1792-1795 NNP denotes EMA
T22952 1796-1805 NN denotes exclusion
T22953 1806-1808 IN denotes of
T22954 1809-1813 NNP denotes CD19
T22955 1813-1814 NNP denotes +
T22956 1815-1820 VBD denotes gated
T22957 1821-1832 NNS denotes splenocytes
T22958 1833-1837 IN denotes from
T22959 1838-1840 NNP denotes WT
T22960 1841-1844 CC denotes and
T22961 1845-1849 NNP denotes LMP1
T22962 1850-1860 JJ denotes transgenic
T22963 1861-1865 NNS denotes mice
T22964 1866-1873 VBG denotes showing
T22965 1874-1884 NN denotes percentage
T22966 1885-1887 IN denotes of
T22967 1888-1894 JJ denotes viable
T22968 1895-1896 NNP denotes B
T22969 1897-1902 NNS denotes cells
T22970 1903-1911 VBD denotes cultured
T22971 1912-1916 IN denotes with
T22972 1917-1918 -LRB- denotes (
T22973 1918-1923 JJ denotes white
T22974 1924-1928 NNS denotes bars
T22975 1928-1929 -RRB- denotes )
T22976 1930-1932 CC denotes or
T22977 1933-1940 IN denotes without
T22978 1941-1942 -LRB- denotes (
T22979 1942-1947 JJ denotes black
T22980 1948-1952 NNS denotes bars
T22981 1952-1953 -RRB- denotes )
T22982 1954-1957 CD denotes IL4
T22983 1958-1961 IN denotes for
T22984 1962-1963 CD denotes 2
T22985 1964-1966 NN denotes d.
T22986 1967-1968 -LRB- denotes (
T22987 1968-1969 NNP denotes C
T22988 1969-1970 -RRB- denotes )
T22989 1971-1975 NNP denotes Flow
T22990 1976-1985 NN denotes cytometry
T22991 1986-1994 NN denotes analysis
T22992 1995-1998 IN denotes for
T22993 1999-2011 JJ denotes incorporated
T22994 2012-2016 NNP denotes BrdU
T22995 2017-2019 IN denotes in
T22996 2020-2022 NNP denotes WT
T22997 2023-2026 CC denotes and
T22998 2027-2031 NNP denotes LMP1
T22999 2032-2042 JJ denotes transgenic
T23000 2043-2051 NN denotes lymphoma
T23001 2052-2057 NNS denotes cells
T23002 2058-2066 VBN denotes cultured
T23003 2067-2071 IN denotes with
T23004 2072-2074 CC denotes or
T23005 2075-2082 IN denotes without
T23006 2083-2086 NNP denotes IL4
T23007 2087-2090 IN denotes for
T23008 2091-2092 CD denotes 2
T23009 2093-2095 NN denotes d.
T23010 2096-2101 VBN denotes Shown
T23011 2102-2105 VBP denotes are
T23012 2106-2109 DT denotes the
T23013 2110-2117 NNS denotes results
T23014 2118-2122 IN denotes from
T23015 2123-2125 NNP denotes WT
T23016 2126-2134 NN denotes lymphoma
T23017 2135-2136 CD denotes 1
T23018 2137-2140 CC denotes and
T23019 2141-2145 CD denotes LMP1
T23020 2146-2156 JJ denotes transgenic
T23021 2157-2165 NN denotes lymphoma
T23022 2166-2167 CD denotes 2
T23023 2167-2168 . denotes .
T23024 2169-2180 NNS denotes Percentages
T23025 2181-2183 IN denotes of
T23026 2184-2189 NNS denotes cells
T23027 2190-2192 IN denotes in
T23028 2193-2197 DT denotes each
T23029 2198-2206 NN denotes quadrant
T23030 2207-2210 VBP denotes are
T23031 2211-2216 VBN denotes shown
T23032 2216-2217 . denotes .
T25521 3852-3859 NN denotes Summary
T25522 3860-3862 IN denotes of
T25523 3863-3871 NNP denotes Analysis
T25524 3872-3881 NNP denotes Performed
T25525 3882-3884 IN denotes on
T25526 3885-3894 NNP denotes Wild-Type
T25527 3895-3898 CC denotes and
T25528 3899-3903 NNP denotes LMP1
T25529 3904-3914 NNP denotes Transgenic
T25530 3915-3924 NNP denotes Lymphomas
R17852 T22851 T22851 ROOT LMP1,LMP1
R17853 T22852 T22852 ROOT Promotes,Promotes
R17854 T22853 T22855 compound B,Survival
R17855 T22854 T22855 compound Cell,Survival
R17856 T22855 T22852 dobj Survival,Promotes
R17857 T22856 T22855 cc and,Survival
R17858 T22857 T22855 conj Proliferation,Survival
R17859 T22858 T22858 ROOT In,In
R17860 T22859 T22861 nmod Vitro,A
R17861 T22860 T22861 punct (,A
R17862 T22861 T22858 pobj A,In
R17863 T22862 T22861 punct ),A
R17864 T22863 T22864 compound MTS,assay
R17865 T22864 T22858 pobj assay,In
R17866 T22865 T22864 prep of,assay
R17867 T22866 T22865 pobj splenocytes,of
R17868 T22867 T22866 prep from,splenocytes
R17869 T22868 T22872 nmod WT,mice
R17870 T22869 T22868 cc and,WT
R17871 T22870 T22868 conj LMP1,WT
R17886 T22885 T22882 conj absence,bars
R17887 T22886 T22888 punct (,bars
R17888 T22887 T22888 amod black,bars
R17889 T22888 T22885 appos bars,absence
R17890 T22889 T22882 punct ),bars
R17891 T22890 T22882 prep of,bars
R17892 T22891 T22890 pobj IL4,of
R17893 T22892 T22875 prep for,were
R17894 T22893 T22894 nummod 3,d
R17895 T22894 T22892 pobj d,for
R17896 T22895 T22875 punct .,were
R17897 T22896 T22897 det The,results
R17898 T22897 T22898 nsubj results,are
R17899 T22898 T22898 ROOT are,are
R17900 T22899 T22902 det the,SEM
R17901 T22900 T22902 amod mean,SEM
R17902 T22901 T22902 compound ±,SEM
R17903 T22902 T22898 attr SEM,are
R17904 T22903 T22902 prep of,SEM
R17905 T22904 T22905 compound triplicate,samples
R17906 T22905 T22903 pobj samples,of
R17907 T22906 T22902 acl averaged,SEM
R17908 T22907 T22906 prep from,averaged
R17909 T22908 T22909 amod multiple,mice
R17910 T22909 T22907 pobj mice,from
R17911 T22910 T22917 advmod where,is
R17912 T22911 T22911 ROOT n,n
R17913 T22912 T22913 det the,number
R17914 T22913 T22917 nsubj number,is
R17915 T22914 T22913 prep of,number
R17916 T22915 T22914 pobj mice,of
R17917 T22916 T22915 acl analyzed,mice
R17918 T22917 T22909 relcl is,mice
R17919 T22918 T22919 mark as,follows
R17920 T22919 T22917 advcl follows,is
R17921 T22920 T22909 punct :,mice
R17922 T22921 T22906 dobj n,averaged
R17923 T22922 T22923 punct =,2
R17924 T22923 T22921 nummod 2,n
R17925 T22924 T22921 prep for,n
R17926 T22925 T22926 compound WT,lymphocytes
R17927 T22926 T22924 pobj lymphocytes,for
R17928 T22927 T22926 cc and,lymphocytes
R17929 T22928 T22929 compound WT,lymphomas
R17930 T22929 T22926 conj lymphomas,lymphocytes
R17931 T22930 T22921 punct ",",n
R17932 T22931 T22933 dep n,11
R17933 T22932 T22933 punct =,11
R17934 T22933 T22921 dep 11,n
R17935 T22934 T22933 prep for,11
R17936 T22935 T22937 nummod LMP1,lymphocytes
R17937 T22936 T22937 amod transgenic,lymphocytes
R17938 T22937 T22934 pobj lymphocytes,for
R17939 T22938 T22933 punct ",",11
R17940 T22939 T22933 cc and,11
R17941 T22940 T22942 amod n,13
R17942 T22941 T22942 punct =,13
R17943 T22942 T22933 conj 13,11
R17944 T22943 T22942 prep for,13
R17945 T22944 T22946 nummod LMP1,lymphomas
R17946 T22945 T22946 amod transgenic,lymphomas
R17947 T22946 T22943 pobj lymphomas,for
R17948 T22947 T22898 punct .,are
R17949 T22948 T22949 punct (,B
R17950 T22949 T22949 ROOT B,B
R17951 T22950 T22949 punct ),B
R17952 T22951 T22952 compound EMA,exclusion
R17953 T22952 T22956 nsubj exclusion,gated
R17954 T22953 T22952 prep of,exclusion
R17955 T22954 T22955 compound CD19,+
R17956 T22955 T22953 pobj +,of
R17957 T22956 T22956 ROOT gated,gated
R17958 T22957 T22956 dobj splenocytes,gated
R17959 T22958 T22957 prep from,splenocytes
R17960 T22959 T22963 nmod WT,mice
R17961 T22960 T22959 cc and,WT
R17962 T22961 T22959 conj LMP1,WT
R17963 T22962 T22963 amod transgenic,mice
R17964 T22963 T22958 pobj mice,from
R17965 T22964 T22956 advcl showing,gated
R17966 T22965 T22964 dobj percentage,showing
R17967 T22966 T22965 prep of,percentage
R17968 T22967 T22969 amod viable,cells
R17969 T22968 T22969 compound B,cells
R17970 T22969 T22966 pobj cells,of
R17971 T22970 T22956 conj cultured,gated
R17972 T22971 T22970 prep with,cultured
R17973 T22972 T22974 punct (,bars
R17974 T22973 T22974 amod white,bars
R17975 T22974 T22971 pobj bars,with
R17976 T22975 T22970 punct ),cultured
R17977 T22976 T22956 cc or,gated
R17978 T22977 T22956 conj without,gated
R17979 T22978 T22980 punct (,bars
R17980 T22979 T22980 amod black,bars
R17981 T22980 T22977 pobj bars,without
R17982 T22981 T22956 punct ),gated
R17983 T22982 T22982 ROOT IL4,IL4
R17984 T22983 T22982 prep for,IL4
R17985 T22984 T22985 nummod 2,d.
R17986 T22985 T22983 pobj d.,for
R17987 T22986 T22987 punct (,C
R17988 T22987 T22982 appos C,IL4
R17989 T22988 T22987 punct ),C
R17990 T22989 T22991 compound Flow,analysis
R17991 T22990 T22991 compound cytometry,analysis
R17992 T22991 T23002 nsubj analysis,cultured
R17993 T22992 T22991 prep for,analysis
R17994 T22993 T22994 amod incorporated,BrdU
R17995 T22994 T22992 pobj BrdU,for
R17996 T22995 T22994 prep in,BrdU
R17997 T22996 T22995 pobj WT,in
R17998 T22997 T22996 cc and,WT
R17999 T22998 T22996 conj LMP1,WT
R18000 T22999 T23001 amod transgenic,cells
R18001 T23000 T23001 compound lymphoma,cells
R18002 T23001 T22992 pobj cells,for
R18003 T23002 T23011 acomp cultured,are
R18004 T23003 T23002 prep with,cultured
R18005 T23004 T23003 cc or,with
R18006 T23005 T23003 conj without,with
R18007 T23006 T23005 pobj IL4,without
R18008 T23007 T23002 prep for,cultured
R18009 T23008 T23009 nummod 2,d.
R18010 T23009 T23010 compound d.,Shown
R18011 T23010 T23007 pobj Shown,for
R18012 T23011 T23011 ROOT are,are
R18013 T23012 T23013 det the,results
R18014 T23013 T23011 nsubj results,are
R18015 T23014 T23013 prep from,results
R18016 T23015 T23016 compound WT,lymphoma
R18017 T23016 T23014 pobj lymphoma,from
R18018 T23017 T23016 nummod 1,lymphoma
R18019 T23018 T23016 cc and,lymphoma
R18020 T23019 T23021 nummod LMP1,lymphoma
R18021 T23020 T23021 amod transgenic,lymphoma
R18022 T23021 T23016 conj lymphoma,lymphoma
R18023 T23022 T23021 nummod 2,lymphoma
R18024 T23023 T23011 punct .,are
R18025 T23024 T23031 nsubjpass Percentages,shown
R18026 T23025 T23024 prep of,Percentages
R18027 T23026 T23025 pobj cells,of
R18028 T23027 T23024 prep in,Percentages
R18029 T23028 T23029 det each,quadrant
R18030 T23029 T23027 pobj quadrant,in
R18031 T23030 T23031 auxpass are,shown
R18032 T23031 T23031 ROOT shown,shown
R18033 T23032 T23031 punct .,shown
R19778 T25521 T25521 ROOT Summary,Summary
R19779 T25522 T25521 prep of,Summary
R19780 T25523 T25522 pobj Analysis,of
R19781 T25524 T25521 npadvmod Performed,Summary
R19782 T25525 T25524 prep on,Performed
R19783 T25526 T25525 pobj Wild-Type,on
R19784 T25527 T25526 cc and,Wild-Type
R19785 T25528 T25530 compound LMP1,Lymphomas
R19786 T25529 T25530 compound Transgenic,Lymphomas
R17875 T22874 T22875 nsubj Splenocytes,were
R17876 T22875 T22875 ROOT were,were
R17877 T22876 T22875 acomp cultured,were
R17878 T22877 T22876 prep in,cultured
R17879 T22878 T22879 det the,presence
R17880 T22879 T22877 pobj presence,in
R17881 T22880 T22882 punct (,bars
R17882 T22881 T22882 amod grey,bars
R17883 T22882 T22879 appos bars,presence
R17884 T22883 T22882 punct ),bars
R17885 T22884 T22882 cc or,bars
R17872 T22871 T22872 amod transgenic,mice
R17873 T22872 T22867 pobj mice,from
R17874 T22873 T22864 punct .,assay
R19787 T25530 T25526 conj Lymphomas,Wild-Type

GO-BP

Id Subject Object Predicate Lexical cue
T5544 660-670 http://purl.obolibrary.org/obo/GO_0008152 denotes metabolism
T5545 1116-1119 http://purl.obolibrary.org/obo/GO_0007568 denotes age
T5546 1283-1286 http://purl.obolibrary.org/obo/GO_0007568 denotes age

GO-CC

Id Subject Object Predicate Lexical cue
T6091 202-206 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T6092 787-792 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6093 894-899 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6094 2251-2256 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6095 2466-2471 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6096 2574-2579 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6097 2700-2705 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6098 2915-2920 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6099 3154-3159 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6100 3273-3278 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T6090 67-71 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T23041 1897-1902 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T23042 2052-2057 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T23043 2184-2189 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

sentences

Id Subject Object Predicate Lexical cue
T5525 0-56 Sentence denotes LMP1 Promotes B Cell Survival and Proliferation In Vitro
T5526 57-155 Sentence denotes Primary B cell cultures can be maintained through CD40 ligation and supplementation with IL4 [32].
T5527 156-462 Sentence denotes To investigate whether LMP1 affects primary B cell survival and proliferation, splenocytes were cultured in the presence or absence of IL4 and analyzed by MTS as a metabolic marker, by ethidium monoazide (EMA) exclusion for viability, and by 5-bromo-2′-deoxy-uridine (BrdU) incorporation for proliferation.
T5528 463-615 Sentence denotes In the MTS assay, as expected, splenocytes from wild-type mice did not survive even with the addition of IL4 due to a lack of CD40 ligation (Figure 3A).
T5529 616-747 Sentence denotes In contrast, LMP1 splenocytes had increased metabolism even in the absence of IL4, which was further enhanced upon addition of IL4.
T5530 748-864 Sentence denotes Wild-type and LMP1 transgenic lymphoma cells had high levels of MTS activity even in the absence of IL4 (Figure 3A).
T5531 865-1042 Sentence denotes The LMP1 transgenic lymphoma cells had approximately 4-fold higher MTS activity than the normal transgenic lymphocytes and were at least 2-fold higher than the control lymphoma.
T5532 1043-1160 Sentence denotes As previously published, lymphoma usually develops in mice over 12 mo of age and all mice are sacrificed by 18–20 mo.
T5533 1161-1249 Sentence denotes The ages of the transgenic mice with or without lymphoma ranged between 6 and 20 mo old.
T5534 1250-1304 Sentence denotes There was no correlation between age and MTS activity.
T5535 2220-2424 Sentence denotes EMA exclusion of CD19+ gated B cells prepared from two wild-type and two LMP1 transgenic mice indicated a 2-fold increase in viability in the LMP1 transgenic lymphocytes compared to wild-type lymphocytes.
T5536 2425-2630 Sentence denotes Two examples of LMP1 transgenic lymphoma cells had greatly increased viability that was not increased by IL4 treatment, indicating that the lymphoma cells are independent of IL4 co-stimulation (Figure 3B).
T5537 2631-2787 Sentence denotes Enhancement in MTS activity was observed in LMP1 transgenic lymphoma cells by the addition of IL4; however, EMA exclusion did not reveal a similar increase.
T5538 2788-2921 Sentence denotes This could reflect a difference for IL4 requirement in the metabolic activity versus the viability of LMP1 transgenic lymphoma cells.
T5539 2922-3139 Sentence denotes Although expression of LMP1 could enhance survival of non-malignant primary lymphocytes, BrdU incorporation revealed that LMP1 expression alone was not sufficient to induce proliferation in culture (unpublished data).
T5540 3140-3243 Sentence denotes Only lymphoma cells had detectable levels of BrdU incorporation detected by flow cytometry (Figure 3C).
T5541 3244-3432 Sentence denotes Interestingly, LMP1 lymphoma cells had significantly higher levels of proliferation in comparison to the spontaneous lymphoma that developed in an LMP1-negative littermate (25% versus 4%).
T5542 3433-3692 Sentence denotes This higher level of proliferation was observed in lymphomas that express both high (Table 1, LMP1-L2 and LMP1-L3) and low (Table 1, LMP1-L5) levels of LMP1, suggesting that even small amounts of LMP1 is sufficient to induce dramatic effects in proliferation.
T5543 3693-3842 Sentence denotes The level of proliferation was not enhanced upon IL4 addition, confirming the IL4 independence observed in the viability studies (Figure 3C; Table1).
T22656 1315-1371 Sentence denotes LMP1 Promotes B Cell Survival and Proliferation In Vitro
T22657 1372-1434 Sentence denotes (A) MTS assay of splenocytes from WT and LMP1 transgenic mice.
T22658 1435-1528 Sentence denotes Splenocytes were cultured in the presence (grey bars) or absence (black bars) of IL4 for 3 d.
T22659 1529-1787 Sentence denotes The results are the mean ± SEM of triplicate samples averaged from multiple mice where “n” the number of mice analyzed is as follows: n = 2 for WT lymphocytes and WT lymphomas, n = 11 for LMP1 transgenic lymphocytes, and n = 13 for LMP1 transgenic lymphomas.
T22660 1788-1966 Sentence denotes (B) EMA exclusion of CD19+ gated splenocytes from WT and LMP1 transgenic mice showing percentage of viable B cells cultured with (white bars) or without (black bars) IL4 for 2 d.
T22661 1967-2095 Sentence denotes (C) Flow cytometry analysis for incorporated BrdU in WT and LMP1 transgenic lymphoma cells cultured with or without IL4 for 2 d.
T22662 2096-2168 Sentence denotes Shown are the results from WT lymphoma 1 and LMP1 transgenic lymphoma 2.
T22663 2169-2217 Sentence denotes Percentages of cells in each quadrant are shown.
T25509 3852-3924 Sentence denotes Summary of Analysis Performed on Wild-Type and LMP1 Transgenic Lymphomas
T91 0-56 Sentence denotes LMP1 Promotes B Cell Survival and Proliferation In Vitro
T92 57-155 Sentence denotes Primary B cell cultures can be maintained through CD40 ligation and supplementation with IL4 [32].
T93 156-462 Sentence denotes To investigate whether LMP1 affects primary B cell survival and proliferation, splenocytes were cultured in the presence or absence of IL4 and analyzed by MTS as a metabolic marker, by ethidium monoazide (EMA) exclusion for viability, and by 5-bromo-2′-deoxy-uridine (BrdU) incorporation for proliferation.
T94 463-615 Sentence denotes In the MTS assay, as expected, splenocytes from wild-type mice did not survive even with the addition of IL4 due to a lack of CD40 ligation (Figure 3A).
T95 616-747 Sentence denotes In contrast, LMP1 splenocytes had increased metabolism even in the absence of IL4, which was further enhanced upon addition of IL4.
T96 748-864 Sentence denotes Wild-type and LMP1 transgenic lymphoma cells had high levels of MTS activity even in the absence of IL4 (Figure 3A).
T97 865-1042 Sentence denotes The LMP1 transgenic lymphoma cells had approximately 4-fold higher MTS activity than the normal transgenic lymphocytes and were at least 2-fold higher than the control lymphoma.
T98 1043-1160 Sentence denotes As previously published, lymphoma usually develops in mice over 12 mo of age and all mice are sacrificed by 18–20 mo.
T99 1161-1249 Sentence denotes The ages of the transgenic mice with or without lymphoma ranged between 6 and 20 mo old.
T100 1250-1304 Sentence denotes There was no correlation between age and MTS activity.
T101 1305-1371 Sentence denotes Figure 3 LMP1 Promotes B Cell Survival and Proliferation In Vitro
T102 1372-1434 Sentence denotes (A) MTS assay of splenocytes from WT and LMP1 transgenic mice.
T103 1435-1528 Sentence denotes Splenocytes were cultured in the presence (grey bars) or absence (black bars) of IL4 for 3 d.
T104 1529-1787 Sentence denotes The results are the mean ± SEM of triplicate samples averaged from multiple mice where “n” the number of mice analyzed is as follows: n = 2 for WT lymphocytes and WT lymphomas, n = 11 for LMP1 transgenic lymphocytes, and n = 13 for LMP1 transgenic lymphomas.
T105 1788-1966 Sentence denotes (B) EMA exclusion of CD19+ gated splenocytes from WT and LMP1 transgenic mice showing percentage of viable B cells cultured with (white bars) or without (black bars) IL4 for 2 d.
T106 1967-2095 Sentence denotes (C) Flow cytometry analysis for incorporated BrdU in WT and LMP1 transgenic lymphoma cells cultured with or without IL4 for 2 d.
T107 2096-2168 Sentence denotes Shown are the results from WT lymphoma 1 and LMP1 transgenic lymphoma 2.
T108 2169-2217 Sentence denotes Percentages of cells in each quadrant are shown.
T109 2220-2424 Sentence denotes EMA exclusion of CD19+ gated B cells prepared from two wild-type and two LMP1 transgenic mice indicated a 2-fold increase in viability in the LMP1 transgenic lymphocytes compared to wild-type lymphocytes.
T110 2425-2630 Sentence denotes Two examples of LMP1 transgenic lymphoma cells had greatly increased viability that was not increased by IL4 treatment, indicating that the lymphoma cells are independent of IL4 co-stimulation (Figure 3B).
T111 2631-2787 Sentence denotes Enhancement in MTS activity was observed in LMP1 transgenic lymphoma cells by the addition of IL4; however, EMA exclusion did not reveal a similar increase.
T112 2788-2921 Sentence denotes This could reflect a difference for IL4 requirement in the metabolic activity versus the viability of LMP1 transgenic lymphoma cells.
T113 2922-3139 Sentence denotes Although expression of LMP1 could enhance survival of non-malignant primary lymphocytes, BrdU incorporation revealed that LMP1 expression alone was not sufficient to induce proliferation in culture (unpublished data).
T114 3140-3243 Sentence denotes Only lymphoma cells had detectable levels of BrdU incorporation detected by flow cytometry (Figure 3C).
T115 3244-3432 Sentence denotes Interestingly, LMP1 lymphoma cells had significantly higher levels of proliferation in comparison to the spontaneous lymphoma that developed in an LMP1-negative littermate (25% versus 4%).
T116 3433-3692 Sentence denotes This higher level of proliferation was observed in lymphomas that express both high (Table 1, LMP1-L2 and LMP1-L3) and low (Table 1, LMP1-L5) levels of LMP1, suggesting that even small amounts of LMP1 is sufficient to induce dramatic effects in proliferation.
T117 3693-3842 Sentence denotes The level of proliferation was not enhanced upon IL4 addition, confirming the IL4 independence observed in the viability studies (Figure 3C; Table1).
T118 3843-3924 Sentence denotes Table 1 Summary of Analysis Performed on Wild-Type and LMP1 Transgenic Lymphomas

events-check-again

Id Subject Object Predicate Lexical cue Negation
T6241 0-4 Protein denotes LMP1
T6242 107-111 Protein denotes CD40
T6243 112-120 Binding denotes ligation
T6244 146-149 Protein denotes IL4
T6245 179-183 Protein denotes LMP1
T6246 291-294 Protein denotes IL4
T6247 568-571 Protein denotes IL4
T6248 581-585 Negative_regulation denotes lack
T6249 589-593 Protein denotes CD40
T6250 594-602 Binding denotes ligation
T6251 629-633 Protein denotes LMP1
T6252 683-690 Negative_regulation denotes absence
T6253 694-697 Protein denotes IL4
T6254 743-746 Protein denotes IL4
T6255 762-766 Protein denotes LMP1
T6256 837-844 Negative_regulation denotes absence
T6257 848-851 Protein denotes IL4
T6258 869-873 Protein denotes LMP1
T6259 2237-2241 Protein denotes CD19
T6260 2293-2297 Protein denotes LMP1
T6261 2362-2366 Protein denotes LMP1
T6262 2441-2445 Protein denotes LMP1
T6263 2530-2533 Protein denotes IL4
T6264 2599-2602 Protein denotes IL4
T6265 2675-2679 Protein denotes LMP1
T6266 2725-2728 Protein denotes IL4
T6267 2824-2827 Protein denotes IL4
T6268 2890-2894 Protein denotes LMP1
T6269 2931-2941 Gene_expression denotes expression
T6270 2945-2949 Protein denotes LMP1
T6271 3044-3048 Protein denotes LMP1
T6272 3049-3059 Gene_expression denotes expression
T6273 3259-3263 Protein denotes LMP1
T6274 3391-3395 Protein denotes LMP1
T6275 3396-3404 Negative_regulation denotes negative
T6276 3499-3506 Gene_expression denotes express
T6277 3512-3516 Positive_regulation denotes high
T6278 3527-3531 Protein denotes LMP1
T6279 3539-3543 Protein denotes LMP1
T6280 3552-3555 Positive_regulation denotes low true
T6281 3566-3570 Protein denotes LMP1
T6282 3585-3589 Protein denotes LMP1
T6283 3629-3633 Protein denotes LMP1
T6284 3742-3745 Protein denotes IL4
T6285 3771-3774 Protein denotes IL4
T23081 1315-1319 Protein denotes LMP1
T23082 1413-1417 Protein denotes LMP1
T23083 1516-1519 Protein denotes IL4
T23084 1717-1721 Protein denotes LMP1
T23085 1761-1765 Protein denotes LMP1
T23086 1809-1813 Protein denotes CD19
T23087 1845-1849 Protein denotes LMP1
T23088 1954-1957 Protein denotes IL4
T23089 2027-2031 Protein denotes LMP1
T23090 2083-2086 Protein denotes IL4
T23091 2141-2145 Protein denotes LMP1
T25537 3899-3903 Protein denotes LMP1
T25538 3904-3914 Gene_expression denotes Transgenic
R4857 T6242 T6243 themeOf CD40,ligation
R4858 T6249 T6250 themeOf CD40,ligation
R4859 T6250 T6248 themeOf ligation,lack
R4860 T6253 T6252 themeOf IL4,absence
R4861 T6257 T6256 themeOf IL4,absence
R4862 T6270 T6269 themeOf LMP1,expression
R4863 T6271 T6272 themeOf LMP1,expression
R4864 T6274 T6275 themeOf LMP1,negative
R4865 T6276 T6277 themeOf express,high
R4866 T6276 T6280 themeOf express,low
R4867 T6282 T6276 themeOf LMP1,express
R19790 T25537 T25538 themeOf LMP1,Transgenic

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T6191 0-4 Protein denotes LMP1
T6192 107-111 Protein denotes CD40
T6193 112-120 Binding denotes ligation
T6194 179-183 Protein denotes LMP1
T6195 291-294 Protein denotes IL4
T6196 568-571 Protein denotes IL4
T6197 589-593 Protein denotes CD40
T6198 594-602 Binding denotes ligation
T6199 581-585 Negative_regulation denotes lack
T6200 629-633 Protein denotes LMP1
T6201 694-697 Protein denotes IL4
T6202 743-746 Protein denotes IL4
T6203 717-725 Positive_regulation denotes enhanced
T6204 762-766 Protein denotes LMP1
T6205 812-815 Protein denotes MTS
T6206 869-873 Protein denotes LMP1
T6207 2237-2241 Protein denotes CD19
T6208 2243-2250 Protein denotes gated B
T6209 2293-2297 Protein denotes LMP1
T6210 2362-2366 Protein denotes LMP1
T6211 2441-2445 Protein denotes LMP1
T6212 2599-2602 Protein denotes IL4
T6213 2675-2679 Protein denotes LMP1
T6214 2725-2728 Protein denotes IL4
T6215 2824-2827 Protein denotes IL4
T6216 2890-2894 Protein denotes LMP1
T6217 2828-2839 Positive_regulation denotes requirement
T6218 2945-2949 Protein denotes LMP1
T6219 3011-3015 Protein denotes BrdU
T6220 3044-3048 Protein denotes LMP1
T6221 2931-2941 Gene_expression denotes expression
T6222 3049-3059 Gene_expression denotes expression
T6223 3185-3189 Protein denotes BrdU
T6224 3259-3263 Protein denotes LMP1
T6225 3391-3395 Protein denotes LMP1
T6226 3396-3404 Gene_expression denotes negative
T6227 3527-3531 Protein denotes LMP1
T6228 3532-3534 Protein denotes L2
T6229 3566-3573 Protein denotes LMP1-L5
T6230 3585-3589 Protein denotes LMP1
T6231 3629-3633 Protein denotes LMP1
T6232 3499-3506 Gene_expression denotes express
T6233 3499-3506 Gene_expression denotes express
T6234 3499-3506 Gene_expression denotes express
T6235 3512-3516 Positive_regulation denotes high
T6236 3512-3516 Positive_regulation denotes high
T6237 3512-3516 Positive_regulation denotes high
T6238 3512-3516 Positive_regulation denotes high
T6239 3742-3745 Protein denotes IL4
T6240 3771-3774 Protein denotes IL4
T25536 3899-3914 Protein denotes LMP1 Transgenic
T23066 1315-1319 Protein denotes LMP1
T23067 1406-1408 Protein denotes WT
T23068 1413-1417 Protein denotes LMP1
T23069 1516-1519 Protein denotes IL4
T23070 1717-1721 Protein denotes LMP1
T23071 1761-1765 Protein denotes LMP1
T23072 1809-1814 Protein denotes CD19+
T23073 1838-1840 Protein denotes WT
T23074 1845-1849 Protein denotes LMP1
T23075 2012-2016 Protein denotes BrdU
T23076 2020-2022 Protein denotes WT
T23077 2027-2031 Protein denotes LMP1
T23078 2083-2086 Protein denotes IL4
T23079 2123-2136 Protein denotes WT lymphoma 1
T23080 2141-2145 Protein denotes LMP1
R4842 T6192 T6193 themeOf CD40,ligation
R4843 T6197 T6198 themeOf CD40,ligation
R4844 T6198 T6199 themeOf ligation,lack
R4845 T6201 T6203 themeOf IL4,enhanced
R4846 T6215 T6217 themeOf IL4,requirement
R4847 T6218 T6221 themeOf LMP1,expression
R4848 T6220 T6222 themeOf LMP1,expression
R4849 T6225 T6226 themeOf LMP1,negative
R4850 T6228 T6232 themeOf L2,express
R4851 T6228 T6235 themeOf L2,high
R4852 T6229 T6233 themeOf LMP1-L5,express
R4853 T6230 T6234 themeOf LMP1,express
R4854 T6232 T6236 themeOf express,high
R4855 T6233 T6237 themeOf express,high
R4856 T6234 T6238 themeOf express,high

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Negation
T5480 0-4 Protein denotes LMP1
T5481 107-111 Protein denotes CD40
T5482 112-120 Binding denotes ligation
T5483 146-149 Protein denotes IL4
T22655 2141-2145 Protein denotes LMP1
T22645 1315-1319 Protein denotes LMP1
T22646 1413-1417 Protein denotes LMP1
T22647 1516-1519 Protein denotes IL4
T22648 1717-1721 Protein denotes LMP1
T22649 1761-1765 Protein denotes LMP1
T22650 1809-1813 Protein denotes CD19
T22651 1845-1849 Protein denotes LMP1
T22652 1954-1957 Protein denotes IL4
T22653 2027-2031 Protein denotes LMP1
T22654 2083-2086 Protein denotes IL4
T25507 3899-3903 Protein denotes LMP1
T25508 3904-3914 Gene_expression denotes Transgenic
T5484 179-183 Protein denotes LMP1
T5485 291-294 Protein denotes IL4
T5486 568-571 Protein denotes IL4
T5487 581-585 Negative_regulation denotes lack
T5488 589-593 Protein denotes CD40
T5489 594-602 Binding denotes ligation
T5490 629-633 Protein denotes LMP1
T5491 683-690 Negative_regulation denotes absence
T5492 694-697 Protein denotes IL4
T5493 743-746 Protein denotes IL4
T5494 762-766 Protein denotes LMP1
T5495 837-844 Negative_regulation denotes absence
T5496 848-851 Protein denotes IL4
T5497 869-873 Protein denotes LMP1
T5498 2237-2241 Protein denotes CD19
T5499 2293-2297 Protein denotes LMP1
T5500 2362-2366 Protein denotes LMP1
T5501 2441-2445 Protein denotes LMP1
T5502 2530-2533 Protein denotes IL4
T5503 2599-2602 Protein denotes IL4
T5504 2675-2679 Protein denotes LMP1
T5505 2725-2728 Protein denotes IL4
T5506 2824-2827 Protein denotes IL4
T5507 2890-2894 Protein denotes LMP1
T5508 2931-2941 Gene_expression denotes expression
T5509 2945-2949 Protein denotes LMP1
T5510 3044-3048 Protein denotes LMP1
T5511 3049-3059 Gene_expression denotes expression
T5512 3259-3263 Protein denotes LMP1
T5513 3391-3395 Protein denotes LMP1
T5514 3396-3404 Negative_regulation denotes negative
T5515 3499-3506 Gene_expression denotes express
T5516 3512-3516 Positive_regulation denotes high
T5517 3527-3531 Protein denotes LMP1
T5518 3539-3543 Protein denotes LMP1
T5519 3552-3555 Positive_regulation denotes low true
T5520 3566-3570 Protein denotes LMP1
T5521 3585-3589 Protein denotes LMP1
T5522 3629-3633 Protein denotes LMP1
T5523 3742-3745 Protein denotes IL4
T5524 3771-3774 Protein denotes IL4
R19768 T25507 T25508 themeOf LMP1,Transgenic
R4312 T5481 T5482 themeOf CD40,ligation
R4313 T5488 T5489 themeOf CD40,ligation
R4314 T5489 T5487 themeOf ligation,lack
R4315 T5492 T5491 themeOf IL4,absence
R4316 T5496 T5495 themeOf IL4,absence
R4317 T5509 T5508 themeOf LMP1,expression
R4318 T5510 T5511 themeOf LMP1,expression
R4319 T5513 T5514 themeOf LMP1,negative
R4320 T5515 T5516 themeOf express,high
R4321 T5515 T5519 themeOf express,low
R4322 T5521 T5515 themeOf LMP1,express

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T6037 0-4 P03230 denotes LMP1
T6038 107-111 P25942 denotes CD40
T6039 146-149 P05112 denotes IL4
T6040 179-183 P03230 denotes LMP1
T6041 291-294 P05112 denotes IL4
T6042 568-571 P05112 denotes IL4
T6043 589-593 P25942 denotes CD40
T6044 629-633 P03230 denotes LMP1
T6045 694-697 P05112 denotes IL4
T6046 743-746 P05112 denotes IL4
T6047 762-766 P03230 denotes LMP1
T6048 848-851 P05112 denotes IL4
T6049 869-873 P03230 denotes LMP1
T6050 2237-2241 P15391 denotes CD19
T6051 2293-2297 P03230 denotes LMP1
T6052 2362-2366 P03230 denotes LMP1
T6053 2441-2445 P03230 denotes LMP1
T6054 2530-2533 P05112 denotes IL4
T6055 2599-2602 P05112 denotes IL4
T6056 2675-2679 P03230 denotes LMP1
T6057 2725-2728 P05112 denotes IL4
T6058 2824-2827 P05112 denotes IL4
T6059 2890-2894 P03230 denotes LMP1
T6060 2945-2949 P03230 denotes LMP1
T6061 3044-3048 P03230 denotes LMP1
T6062 3259-3263 P03230 denotes LMP1
T6063 3391-3395 P03230 denotes LMP1
T6064 3527-3531 P03230 denotes LMP1
T6065 3539-3543 P03230 denotes LMP1
T6066 3566-3570 P03230 denotes LMP1
T6067 3585-3589 P03230 denotes LMP1
T6068 3629-3633 P03230 denotes LMP1
T6069 3742-3745 P05112 denotes IL4
T6070 3771-3774 P05112 denotes IL4
T22840 1315-1319 P03230 denotes LMP1
T22841 1413-1417 P03230 denotes LMP1
T22842 1516-1519 P05112 denotes IL4
T22843 1717-1721 P03230 denotes LMP1
T22844 1761-1765 P03230 denotes LMP1
T22845 1809-1813 P15391 denotes CD19
T22846 1845-1849 P03230 denotes LMP1
T22847 1954-1957 P05112 denotes IL4
T22848 2027-2031 P03230 denotes LMP1
T22849 2083-2086 P05112 denotes IL4
T22850 2141-2145 P03230 denotes LMP1
T25520 3899-3903 P03230 denotes LMP1

test2

Id Subject Object Predicate Lexical cue Negation
T5432 0-4 Protein denotes LMP1
T5433 107-111 Protein denotes CD40
T5434 112-120 Binding denotes ligation
T5435 146-149 Protein denotes IL4
T5436 179-183 Protein denotes LMP1
T5437 280-287 Negative_regulation denotes absence
T5438 291-294 Protein denotes IL4
T5439 568-571 Protein denotes IL4
T5440 572-575 Positive_regulation denotes due
T5441 581-585 Negative_regulation denotes lack
T5442 589-593 Protein denotes CD40 true
T5443 594-602 Binding denotes ligation
T5444 629-633 Protein denotes LMP1
T5445 683-690 Negative_regulation denotes absence
T5446 694-697 Protein denotes IL4
T5447 717-725 Positive_regulation denotes enhanced
T5448 743-746 Protein denotes IL4
T5449 762-766 Protein denotes LMP1
T5450 837-844 Negative_regulation denotes absence
T5451 848-851 Protein denotes IL4
T5452 869-873 Protein denotes LMP1
T5453 2237-2241 Protein denotes CD19
T5454 2293-2297 Protein denotes LMP1
T5455 2362-2366 Protein denotes LMP1
T5456 2441-2445 Protein denotes LMP1
T5457 2517-2526 Positive_regulation denotes increased
T5458 2530-2533 Protein denotes IL4
T5459 2599-2602 Protein denotes IL4
T5460 2675-2679 Protein denotes LMP1
T5461 2725-2728 Protein denotes IL4
T5462 2824-2827 Protein denotes IL4
T5463 2890-2894 Protein denotes LMP1
T5464 2931-2941 Gene_expression denotes expression
T5465 2945-2949 Protein denotes LMP1
T5466 3044-3048 Protein denotes LMP1
T5467 3049-3059 Gene_expression denotes expression
T5468 3259-3263 Protein denotes LMP1
T5469 3391-3395 Protein denotes LMP1
T5470 3396-3404 Negative_regulation denotes negative
T5471 3499-3506 Gene_expression denotes express
T5472 3527-3531 Protein denotes LMP1
T5473 3539-3543 Protein denotes LMP1
T5474 3566-3570 Protein denotes LMP1
T5475 3585-3589 Protein denotes LMP1
T5476 3629-3633 Protein denotes LMP1
T5477 3728-3736 Positive_regulation denotes enhanced
T5478 3742-3745 Protein denotes IL4
T5479 3771-3774 Protein denotes IL4
T22634 1315-1319 Protein denotes LMP1
T22635 1413-1417 Protein denotes LMP1
T22636 1516-1519 Protein denotes IL4
T22637 1717-1721 Protein denotes LMP1
T22638 1761-1765 Protein denotes LMP1
T22639 1809-1813 Protein denotes CD19
T22640 1845-1849 Protein denotes LMP1
T22641 1954-1957 Protein denotes IL4
T22642 2027-2031 Protein denotes LMP1
T22643 2083-2086 Protein denotes IL4
T22644 2141-2145 Protein denotes LMP1
T25506 3899-3903 Protein denotes LMP1
R4298 T5433 T5434 themeOf CD40,ligation
R4299 T5438 T5437 themeOf IL4,absence
R4300 T5442 T5443 themeOf CD40,ligation
R4301 T5443 T5441 themeOf ligation,lack
R4302 T5445 T5447 themeOf absence,enhanced
R4303 T5446 T5445 themeOf IL4,absence
R4304 T5451 T5450 themeOf IL4,absence
R4305 T5465 T5464 themeOf LMP1,expression
R4306 T5466 T5467 themeOf LMP1,expression
R4307 T5469 T5470 themeOf LMP1,negative
R4308 T5472 T5471 themeOf LMP1,express
R4309 T5473 T5471 themeOf LMP1,express
R4310 T5474 T5471 themeOf LMP1,express
R4311 T5475 T5471 themeOf LMP1,express